Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Pimozide | hsa00030 | Pentose phosphate pathway | 3.06E-04 | 3 | P60891, P51854, P37837 | PRPS1, TKTL1, TALDO1 | More | | Pimozide | hsa00052 | Galactose metabolism | 1.03E-02 | 2 | P06280, O43451 | GLA, MGAM | More | | Pimozide | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | | Pimozide | hsa00071 | Fatty acid degradation | 3.65E-03 | 4 | O75521, P00325, P11766, P33121 | ECI2, ADH1B, ADH5, ACSL1 | More | | Pimozide | hsa00190 | Oxidative phosphorylation | 2.65E-06 | 3 | Q16718, Q13488, O14521 | NDUFA5, TCIRG1, SDHD | More | | Pimozide | hsa00220 | Arginine biosynthesis | 4.97E-04 | 2 | P15104, P49448 | GLUL, GLUD2 | More | | Pimozide | hsa00230 | Purine metabolism | 1.71E-03 | 7 | Q13370, P21589, P36959, P20839, Q02153, Q13956, P27707 | PDE3B, NT5E, GMPR, IMPDH1, GUCY1B3, PDE6H, DCK | More | | Pimozide | hsa00240 | Pyrimidine metabolism | 3.42E-03 | 3 | P21589, P32320, P27707 | NT5E, CDA, DCK | More | | Pimozide | hsa00250 | Alanine, aspartate and glutamate metabolism | 1.20E-03 | 2 | P49448, P15104 | GLUD2, GLUL | More | | Pimozide | hsa00260 | Glycine, serine and threonine metabolism | 1.99E-02 | 1 | P22557 | ALAS2 | More | | Pimozide | hsa00280 | Valine, leucine and isoleucine degradation | 1.67E-02 | 4 | P55809, Q9HCC0, Q02252, P11310 | OXCT1, MCCC2, ALDH6A1, ACADM | More | | Pimozide | hsa00310 | Lysine degradation | 3.15E-02 | 2 | Q96KQ7, P51648 | EHMT2, ALDH3A2 | More | | Pimozide | hsa00350 | Tyrosine metabolism | 3.40E-02 | 1 | P28332 | ADH6 | More | | Pimozide | hsa00500 | Starch and sucrose metabolism | 1.89E-06 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Pimozide | hsa00512 | Mucin type O-glycan biosynthesis | 3.78E-02 | 2 | O95395, Q8N4A0 | GCNT3, GALNT4 | More | | Pimozide | hsa00520 | Amino sugar and nucleotide sugar metabolism | 1.59E-02 | 3 | Q16222, Q9Y223, P06865 | UAP1, GNE, HEXA | More | | Pimozide | hsa00533 | Glycosaminoglycan biosynthesis - keratan sulfate | 1.91E-02 | 1 | Q9NY97 | B3GNT2 | More | | Pimozide | hsa00534 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin | 4.77E-02 | 1 | Q7LGA3 | HS2ST1 | More | | Pimozide | hsa00561 | Glycerolipid metabolism | 2.21E-02 | 3 | O14494, P06280, P23743 | PLPP1, GLA, DGKA | More | | Pimozide | hsa00565 | Ether lipid metabolism | 3.00E-03 | 1 | Q8N661 | TMEM86B | More | | Pimozide | hsa00590 | Arachidonic acid metabolism | 3.85E-02 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | | Pimozide | hsa00591 | Linoleic acid metabolism | 1.29E-03 | 1 | P11712 | CYP2C9 | More | | Pimozide | hsa00600 | Sphingolipid metabolism | 8.72E-03 | 4 | Q9BX95, O14494, P06280, P15289 | SGPP1, PLPP1, GLA, ARSA | More | | Pimozide | hsa00601 | Glycosphingolipid biosynthesis - lacto and neolacto series | 3.78E-02 | 1 | Q9NY97 | B3GNT2 | More | | Pimozide | hsa00603 | Glycosphingolipid biosynthesis - globo and isoglobo series | 7.10E-03 | 2 | P06865, O75752 | HEXA, B3GALNT1 | More | | Pimozide | hsa00630 | Glyoxylate and dicarboxylate metabolism | 6.37E-05 | 2 | P40925, P15104 | MDH1, GLUL | More | | Pimozide | hsa00640 | Propanoate metabolism | 3.83E-02 | 2 | Q02252, Q9P2R7 | ALDH6A1, SUCLA2 | More | | Pimozide | hsa00670 | One carbon pool by folate | 9.96E-04 | 3 | O95954, P04818, Q99707 | FTCD, TYMS, MTR | More | | Pimozide | hsa00730 | Thiamine metabolism | 5.65E-05 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Pimozide | hsa00760 | Nicotinate and nicotinamide metabolism | 9.09E-03 | 1 | P21589 | NT5E | More | | Pimozide | hsa00770 | Pantothenate and CoA biosynthesis | 2.26E-04 | 3 | O95498, O95497, Q9NRN7 | VNN2, VNN1, AASDHPPT | More | | Pimozide | hsa00830 | Retinol metabolism | 2.20E-02 | 4 | P00325, P11766, Q9BPW9, O75911 | ADH1B, ADH5, DHRS9, DHRS3 | More | | Pimozide | hsa00910 | Nitrogen metabolism | 1.20E-03 | 2 | P15104, P49448 | GLUL, GLUD2 | More | | Pimozide | hsa00920 | Sulfur metabolism | 3.01E-02 | 1 | O95571 | ETHE1 | More | | Pimozide | hsa00970 | Aminoacyl-tRNA biosynthesis | 3.63E-07 | 4 | O95363, P54136, P14868, Q15046 | FARS2, RARS1, DARS, KARS | More | | Pimozide | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 8.40E-04 | 3 | P78417, P28332, P11712 | GSTO1, ADH6, CYP2C9 | More | | Pimozide | hsa00982 | Drug metabolism - cytochrome P450 | 8.40E-04 | 3 | P11712, P78417, P28332 | CYP2C9, GSTO1, ADH6 | More | | Pimozide | hsa00983 | Drug metabolism - other enzymes | 1.18E-04 | 5 | P04183, P20839, P32320, P05164, Q16772 | TK1, IMPDH1, CDA, MPO, GSTA3 | More | | Pimozide | hsa01100 | Metabolic pathways | 5.77E-03 | 45 | Q9NR34, Q9Y234, P05089, Q99707, P29218, P11310, P27707, P32320, Q13370, P36959, Q13956, P22748, P55809, P06280, Q16875, O43286, O43451, P30043, P05186, P24666, Q02252, O60701, O14772, O95954, Q9HCC0, P33121, Q02318, P04406, P57054, Q9UNP4, O15466, Q9BX95, P09960, P32321, Q9P2R7, Q9BPW9, O75911, Q9UHY7, P43490, P46976, P35573, P06737, Q13488, Q16718, Q02809 | MAN1C1, LIPT1, ARG1, MTR, IMPA1, ACADM, DCK, CDA, PDE3B, GMPR, PDE6H, CA4, OXCT1, GLA, PFKFB3, B4GALT5, MGAM, BLVRB, ALPL, ACP1, ALDH6A1, UGDH, FPGT, FTCD, MCCC2, ACSL1, CYP27A1, GAPDH, PIGP, ST3GAL5, ST8SIA5, SGPP1, LTA4H, DCTD, SUCLA2, DHRS9, DHRS3, ENOPH1, PBEF1, GYG1, AGL, PYGL, TCIRG1, NDUFA5, PLOD1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9NR34 | MAN1C1 | Mannosyl-oligosaccharide 1,2-alpha-mannosidase IC | -0.716 | O15182 | CETN3 | Centrin-3 | Q9Y234 | LIPT1 | Lipoyltransferase 1, mitochondrial | 0.727 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P05089 | ARG1 | Arginase-1 | 0.702 | O15182 | CETN3 | Centrin-3 | Q99707 | MTR | Methionine synthase | 0.924 | O15182 | CETN3 | Centrin-3 | P29218 | IMPA1 | Inositol monophosphatase 1 | 0.739 | O15182 | CETN3 | Centrin-3 | P11310 | ACADM | Medium-chain specific acyl-CoA dehydrogenase, mitochondrial | 0.881 | O15182 | CETN3 | Centrin-3 | P27707 | DCK | Deoxycytidine kinase | 0.937 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P32320 | CDA | Cytidine deaminase | 0.701 | O15182 | CETN3 | Centrin-3 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0.707 | O15182 | CETN3 | Centrin-3 | P36959 | GMPR | GMP reductase 1 | -0.724 | O15182 | CETN3 | Centrin-3 | Q13956 | PDE6H | Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0.857 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P22748 | CA4 | Carbonic anhydrase 4 | 0.767 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P55809 | OXCT1 | Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial | -0.746 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P06280 | GLA | Alpha-galactosidase A | 0.714 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | 0.849 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O43286 | B4GALT5 | Beta-1,4-galactosyltransferase 5 | 0.917 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O43451 | MGAM | Maltase-glucoamylase | 0.871 | O15182 | CETN3 | Centrin-3 | P30043 | BLVRB | Flavin reductase | -0.859 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | 0.901 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P24666 | ACP1 | Low molecular weight phosphotyrosine protein phosphatase | -0.832 | O15182 | CETN3 | Centrin-3 | Q02252 | ALDH6A1 | Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial | 0.801 | O15182 | CETN3 | Centrin-3 | O60701 | UGDH | UDP-glucose 6-dehydrogenase | 0.717 | O15182 | CETN3 | Centrin-3 | O14772 | FPGT | Fucose-1-phosphate guanylyltransferase | 0.862 | O15182 | CETN3 | Centrin-3 | O95954 | FTCD | Formimidoyltransferase-cyclodeaminase | -0.706 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9HCC0 | MCCC2 | Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial | -0.782 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P33121 | ACSL1 | Long-chain-fatty-acid--CoA ligase 1 | 0.886 | O15182 | CETN3 | Centrin-3 | Q02318 | CYP27A1 | Sterol 26-hydroxylase, mitochondrial | -0.805 | O15182 | CETN3 | Centrin-3 | P04406 | GAPDH | Glyceraldehyde-3-phosphate dehydrogenase | -0.765 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P57054 | PIGP | Phosphatidylinositol N-acetylglucosaminyltransferase subunit P | -0.881 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9UNP4 | ST3GAL5 | Lactosylceramide alpha-2,3-sialyltransferase | -0.819 | O15182 | CETN3 | Centrin-3 | O15466 | ST8SIA5 | Alpha-2,8-sialyltransferase 8E | -0.748 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9BX95 | SGPP1 | Sphingosine-1-phosphate phosphatase 1 | -0.743 | O15182 | CETN3 | Centrin-3 | P09960 | LTA4H | Leukotriene A-4 hydrolase | -0.728 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P32321 | DCTD | Deoxycytidylate deaminase | -0.748 | O15182 | CETN3 | Centrin-3 | Q9P2R7 | SUCLA2 | Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial | 0.84 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | 0.817 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O75911 | DHRS3 | Short-chain dehydrogenase/reductase 3 | -0.81 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9UHY7 | ENOPH1 | Enolase-phosphatase E1 | -0.737 | O15182 | CETN3 | Centrin-3 | Q9UHY7 | ENOPH1 | Enolase-phosphatase E1 | 0.707 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | 0.883 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P46976 | GYG1 | Glycogenin-1 | 0.817 | O15182 | CETN3 | Centrin-3 | P35573 | AGL | Glycogen debranching enzyme | 0.749 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P06737 | PYGL | Glycogen phosphorylase, liver form | 0.863 | O15182 | CETN3 | Centrin-3 | Q13488 | TCIRG1 | V-type proton ATPase 116 kDa subunit a 3 | -0.767 | O15182 | CETN3 | Centrin-3 | Q16718 | NDUFA5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | 0.785 | O15182 | CETN3 | Centrin-3 | Q02809 | PLOD1 | Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 | -0.849 |
| Pimozide | hsa01200 | Carbon metabolism | 4.32E-02 | 3 | P51854, P37837, P60891 | TKTL1, TALDO1, PRPS1 | More | | Pimozide | hsa01210 | 2-Oxocarboxylic acid metabolism | 6.96E-04 | 1 | P50213 | IDH3A | More | | Pimozide | hsa01230 | Biosynthesis of amino acids | 1.16E-03 | 4 | P51854, P60891, P15104, P37837 | TKTL1, PRPS1, GLUL, TALDO1 | More | | Pimozide | hsa01521 | EGFR tyrosine kinase inhibitor resistance | 3.18E-04 | 2 | P04049, P08069 | RAF1, IGF1R | More | | Pimozide | hsa01522 | Endocrine resistance | 4.22E-03 | 5 | P22694, P04049, P08069, P10415, Q13323 | PRKACB, RAF1, IGF1R, BCL2, BIK | More | | Pimozide | hsa01523 | Antifolate resistance | 3.80E-02 | 2 | Q92820, P04818 | GGH, TYMS | More | | Pimozide | hsa01524 | Platinum drug resistance | 4.45E-02 | 4 | P10415, Q13489, P78417, P43246 | BCL2, BIRC3, GSTO1, MSH2 | More | | Pimozide | hsa02010 | ABC transporters | 1.99E-04 | 4 | P45844, P08183, Q8IZY2, Q99758 | ABCG1, ABCB1, ABCA7, ABCA3 | More | | Pimozide | hsa03008 | Ribosome biogenesis in eukaryotes | 1.46E-02 | 4 | Q9NYH9, P78345, Q9BVP2, Q9GZY0 | UTP6, RPP38, GNL3, NXF2; NXF2B | More | | Pimozide | hsa03013 | RNA transport | 1.41E-06 | 21 | P62826, P52298, Q09161, O14893, P61326, P38919, Q15287, Q9UBU9, Q9GZY0, P37198, Q7Z3B4, P35658, P63279, Q14152, P55884, O15371, O75822, P78345, P20042, Q9Y6A5, Q53GS7 | RAN, NCBP2, NCBP1, GEMIN2, MAGOH, EIF4A3, RNPS1, NXF1, NXF2; NXF2B, NUP62, NUP54, NUP214, UBE2I, EIF3A, EIF3B, EIF3D, EIF3J, RPP38, EIF2S2, TACC3, GLE1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P05976 | MYL1 | Myosin light chain 1/3, skeletal muscle isoform | P62826 | RAN | GTP-binding nuclear protein Ran | 0.715 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P52298 | NCBP2 | Nuclear cap-binding protein subunit 2 | 0.915 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P52298 | NCBP2 | Nuclear cap-binding protein subunit 2 | 0.888 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q09161 | NCBP1 | Nuclear cap-binding protein subunit 1 | 0.742 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | O14893 | GEMIN2 | Gem-associated protein 2 | 0.853 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P61326 | MAGOH | Protein mago nashi homolog | 0.764 | P49768 | PSEN1 | Presenilin-1 | P38919 | EIF4A3 | Eukaryotic initiation factor 4A-III | 0.808 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | Q15287 | RNPS1 | RNA-binding protein with serine-rich domain 1 | 0.756 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | Q9UBU9 | NXF1 | Nuclear RNA export factor 1 | 0.723 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | Q9GZY0 | NXF2; NXF2B | Nuclear RNA export factor 2 | 0.746 | P49768 | PSEN1 | Presenilin-1 | P37198 | NUP62 | Nuclear pore glycoprotein p62 | -0.716 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q7Z3B4 | NUP54 | Nucleoporin p54 | 0.774 | P49768 | PSEN1 | Presenilin-1 | P35658 | NUP214 | Nuclear pore complex protein Nup214 | -0.768 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P35658 | NUP214 | Nuclear pore complex protein Nup214 | -0.725 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P35658 | NUP214 | Nuclear pore complex protein Nup214 | -0.751 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P63279 | UBE2I | SUMO-conjugating enzyme UBC9 | 0.736 | P05976 | MYL1 | Myosin light chain 1/3, skeletal muscle isoform | P63279 | UBE2I | SUMO-conjugating enzyme UBC9 | 0.742 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | Q14152 | EIF3A | Eukaryotic translation initiation factor 3 subunit A | 0.707 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q14152 | EIF3A | Eukaryotic translation initiation factor 3 subunit A | 0.734 | P49768 | PSEN1 | Presenilin-1 | P55884 | EIF3B | Eukaryotic translation initiation factor 3 subunit B | -0.71 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P55884 | EIF3B | Eukaryotic translation initiation factor 3 subunit B | -0.731 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | O15371 | EIF3D | Eukaryotic translation initiation factor 3 subunit D | 0.77 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | O75822 | EIF3J | Eukaryotic translation initiation factor 3 subunit J | 0.788 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | O75822 | EIF3J | Eukaryotic translation initiation factor 3 subunit J | 0.837 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P78345 | RPP38 | Ribonuclease P protein subunit p38 | 0.869 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P78345 | RPP38 | Ribonuclease P protein subunit p38 | 0.852 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P20042 | EIF2S2 | Eukaryotic translation initiation factor 2 subunit 2 | 0.733 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | Q9Y6A5 | TACC3 | Transforming acidic coiled-coil-containing protein 3 | -0.815 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q9Y6A5 | TACC3 | Transforming acidic coiled-coil-containing protein 3 | -0.812 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | Q53GS7 | GLE1 | mRNA export factor GLE1 | -0.723 |
| Pimozide | hsa03015 | mRNA surveillance pathway | 1.09E-03 | 6 | O43148, Q16537, P61326, Q9GZY0, P52298, Q53GS7 | RNMT, PPP2R5E, MAGOH, NXF2; NXF2B, NCBP2, GLE1 | More | | Pimozide | hsa03020 | RNA polymerase | 4.40E-02 | 2 | P24928, P62487 | POLR2A, POLR2G | More | | Pimozide | hsa03022 | Basal transcription factors | 3.32E-02 | 2 | O00268, Q15544 | TAF4, TAF11 | More | | Pimozide | hsa03040 | Spliceosome | 5.91E-16 | 26 | Q14562, O43143, O60508, P17844, O14776, P08579, Q15427, P26368, O75940, P52298, P38159, P09651, P61978, Q15365, O75494, Q13595, Q07955, Q01130, P84103, Q13243, P11142, Q9Y2W2, O95777, O43447, O75643, P61326 | DHX8, DHX15, CDC40, DDX5, TCERG1, SNRPB2, SF3B4, U2AF2, SMNDC1, NCBP2, RBMX, HNRNPA1, HNRPK, PCBP1, FUSIP1, TRA2A, SFRS1, SFRS2, SFRS3, SFRS5, HSPA8, WBP11, LSM8, PPIH, ASCC3L1, MAGOH | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P0DP23 | CALM1 | Calmodulin-1 | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | 0.942 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | -0.708 | P0DP25 | CALM3 | Calmodulin-3 | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | 0.942 | P0DP24 | CALM2 | Calmodulin-2 | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | 0.942 | P0DP23 | CALM1 | Calmodulin-1 | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | 0.963 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | -0.76 | P0DP25 | CALM3 | Calmodulin-3 | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | 0.963 | P0DP24 | CALM2 | Calmodulin-2 | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | 0.963 | P0DP23 | CALM1 | Calmodulin-1 | O60508 | CDC40 | Pre-mRNA-processing factor 17 | 0.828 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | O60508 | CDC40 | Pre-mRNA-processing factor 17 | -0.837 | P07948 | LYN | Tyrosine-protein kinase Lyn | O60508 | CDC40 | Pre-mRNA-processing factor 17 | -0.814 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O60508 | CDC40 | Pre-mRNA-processing factor 17 | -0.812 | P0DP25 | CALM3 | Calmodulin-3 | O60508 | CDC40 | Pre-mRNA-processing factor 17 | 0.828 | P0DP24 | CALM2 | Calmodulin-2 | O60508 | CDC40 | Pre-mRNA-processing factor 17 | 0.828 | P0DP24 | CALM2 | Calmodulin-2 | P17844 | DDX5 | Probable ATP-dependent RNA helicase DDX5 | 0.734 | O15182 | CETN3 | Centrin-3 | O14776 | TCERG1 | Transcription elongation regulator 1 | 0.758 | P0DP23 | CALM1 | Calmodulin-1 | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | 0.781 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | -0.702 | P07948 | LYN | Tyrosine-protein kinase Lyn | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | -0.739 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | -0.822 | P0DP25 | CALM3 | Calmodulin-3 | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | 0.781 | P0DP24 | CALM2 | Calmodulin-2 | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | 0.781 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | Q15427 | SF3B4 | Splicing factor 3B subunit 4 | 0.71 | P07948 | LYN | Tyrosine-protein kinase Lyn | P26368 | U2AF2 | Splicing factor U2AF 65 kDa subunit | -0.775 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P26368 | U2AF2 | Splicing factor U2AF 65 kDa subunit | -0.751 | O15182 | CETN3 | Centrin-3 | O75940 | SMNDC1 | Survival of motor neuron-related-splicing factor 30 | 0.859 | O15182 | CETN3 | Centrin-3 | P52298 | NCBP2 | Nuclear cap-binding protein subunit 2 | 0.701 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P38159 | RBMX | RNA-binding motif protein, X chromosome | 0.733 | O15182 | CETN3 | Centrin-3 | P09651 | HNRNPA1 | Heterogeneous nuclear ribonucleoprotein A1 | 0.757 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P61978 | HNRPK | Heterogeneous nuclear ribonucleoprotein K | 0.784 | P0DP24 | CALM2 | Calmodulin-2 | Q15365 | PCBP1 | Poly(rC)-binding protein 1 | 0.75 | O15182 | CETN3 | Centrin-3 | O75494 | FUSIP1 | Serine/arginine-rich splicing factor 10 | 0.85 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q13595 | TRA2A | Transformer-2 protein homolog alpha | -0.742 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13595 | TRA2A | Transformer-2 protein homolog alpha | -0.74 | P0DP23 | CALM1 | Calmodulin-1 | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | 0.914 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | -0.749 | P0DP25 | CALM3 | Calmodulin-3 | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | 0.914 | P0DP24 | CALM2 | Calmodulin-2 | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | 0.914 | P0DP23 | CALM1 | Calmodulin-1 | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | 0.841 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | -0.835 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | -0.716 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | -0.798 | P0DP25 | CALM3 | Calmodulin-3 | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | 0.841 | P0DP24 | CALM2 | Calmodulin-2 | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | 0.841 | P07948 | LYN | Tyrosine-protein kinase Lyn | P84103 | SFRS3 | Serine/arginine-rich splicing factor 3 | -0.79 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P84103 | SFRS3 | Serine/arginine-rich splicing factor 3 | -0.773 | P0DP23 | CALM1 | Calmodulin-1 | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | 0.784 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | -0.781 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | -0.822 | P0DP25 | CALM3 | Calmodulin-3 | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | 0.784 | P0DP24 | CALM2 | Calmodulin-2 | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | 0.784 | P0DP23 | CALM1 | Calmodulin-1 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.804 | P07948 | LYN | Tyrosine-protein kinase Lyn | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | -0.732 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.766 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | -0.802 | P0DP25 | CALM3 | Calmodulin-3 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.804 | P0DP24 | CALM2 | Calmodulin-2 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.804 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q9Y2W2 | WBP11 | WW domain-binding protein 11 | -0.734 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q9Y2W2 | WBP11 | WW domain-binding protein 11 | -0.743 | O15182 | CETN3 | Centrin-3 | O95777 | LSM8 | U6 snRNA-associated Sm-like protein LSm8 | 0.723 | P0DP23 | CALM1 | Calmodulin-1 | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | 0.748 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | -0.761 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | -0.766 | P0DP25 | CALM3 | Calmodulin-3 | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | 0.748 | P0DP24 | CALM2 | Calmodulin-2 | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | 0.748 | P07948 | LYN | Tyrosine-protein kinase Lyn | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | -0.742 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | -0.745 | O15182 | CETN3 | Centrin-3 | P61326 | MAGOH | Protein mago nashi homolog | 0.811 |
| Pimozide | hsa03050 | Proteasome | 4.01E-05 | 4 | P43686, P62195, P28070, P40306 | PSMC4, PSMC5, PSMB4, PSMB10 | More | | Pimozide | hsa03060 | Protein export | 1.43E-02 | 2 | P37108, Q15005 | SRP14, SPCS2 | More | | Pimozide | hsa03320 | PPAR signaling pathway | 2.18E-02 | 2 | O00767, Q02318 | SCD, CYP27A1 | More | | Pimozide | hsa03430 | Mismatch repair | 4.38E-02 | 1 | P20585 | MSH3 | More | | Pimozide | hsa03450 | Non-homologous end-joining | 4.21E-02 | 1 | P13010 | XRCC5 | More | | Pimozide | hsa03460 | Fanconi anemia pathway | 4.00E-04 | 4 | Q9NPI8, O94782, O60673, Q9UNA4 | FANCF, USP1, REV3L, POLI | More | | Pimozide | hsa04010 | MAPK signaling pathway | 1.69E-03 | 2 | P04049, P08069 | RAF1, IGF1R | More | | Pimozide | hsa04012 | ErbB signaling pathway | 6.03E-04 | 7 | P21860, P16333, Q13557, P19174, O14944, P01106, P04049 | ERBB3, NCK1, CAMK2D, PLCG1, EREG, MYC, RAF1 | More | | Pimozide | hsa04014 | Ras signaling pathway | 6.20E-05 | 15 | P04049, P31751, P42338, P20827, P49767, P08069, Q13009, P17252, Q15311, Q7LDG7, P0DP23, P62873, P63218, P50151, P19174 | RAF1, AKT2, PIK3CB, EFNA1, VEGFC, IGF1R, TIAM1, PRKCA, RALBP1, RASGRP2, CALM1, GNB1, GNG5, GNG10, PLCG1 | More | | Pimozide | hsa04015 | Rap1 signaling pathway | 8.85E-06 | 17 | P04049, P20827, P49767, P08069, P06213, Q96FS4, P11215, Q13009, O00522, Q7LDG7, Q08828, P51828, P42338, P31751, P0DP23, P17252, P19174 | RAF1, EFNA1, VEGFC, IGF1R, INSR, SIPA1, ITGAM, TIAM1, KRIT1, RASGRP2, ADCY1, ADCY7, PIK3CB, AKT2, CALM1, PRKCA, PLCG1 | More | | Pimozide | hsa04020 | Calcium signaling pathway | 6.53E-09 | 14 | P27987, Q96DU7, Q08828, P45880, Q13557, P17252, P21860, O15399, P19174, P61073, P0DP23, P51828, P23634, P49767 | ITPKB, ITPKC, ADCY1, VDAC2, CAMK2D, PRKCA, ERBB3, GRIN2D, PLCG1, CXCR4, CALM1, ADCY7, ATP2B4, VEGFC | More | | Pimozide | hsa04022 | cGMP-PKG signaling pathway | 1.03E-03 | 9 | P04049, Q99941, P18848, P23634, Q8WYR1, P51828, P05141, P45880, P0DP24 | RAF1, CREBL1, ATF4, ATP2B4, PIK3R5, ADCY7, SLC25A5, VDAC2, CALM2 | More | | Pimozide | hsa04024 | cAMP signaling pathway | 1.25E-03 | 10 | Q08828, P51828, P31751, P0DP23, P23634, P04049, Q13557, Q13370, O15399, Q13009 | ADCY1, ADCY7, AKT2, CALM1, ATP2B4, RAF1, CAMK2D, PDE3B, GRIN2D, TIAM1 | More | | Pimozide | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 4.48E-02 | 5 | P09341, P19875, P25024, P25025, P14784 | CXCL1, CXCL2, CXCR1, CXCR2, IL2RB | More | | Pimozide | hsa04062 | Chemokine signaling pathway | 4.48E-07 | 28 | P51684, P25024, P25025, P09341, P19875, Q8NHW4, P47992, Q9UBD3, P09769, P07948, P42338, P19174, P62873, P63218, P50151, P43250, P49407, Q08881, Q08828, P51828, Q7LDG7, Q13009, P14598, P42224, P31751, P04049, P49841, Q8WYR1 | CCR6, CXCR1, CXCR2, CXCL1, CXCL2, CCL4L2, XCL1, XCL2, FGR, LYN, PIK3CB, PLCG1, GNB1, GNG5, GNG10, GRK6, ARRB1, ITK, ADCY1, ADCY7, RASGRP2, TIAM1, NCF1, STAT1, AKT2, RAF1, GSK3B, PIK3R5 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P0DP23 | CALM1 | Calmodulin-1 | P51684 | CCR6 | C-C chemokine receptor type 6 | -0.734 | Q13547 | HDAC1 | Histone deacetylase 1 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | -0.803 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | 1 | Q13547 | HDAC1 | Histone deacetylase 1 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | -0.719 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | 0.929 | Q13547 | HDAC1 | Histone deacetylase 1 | P09341 | CXCL1 | Growth-regulated alpha protein | -0.736 | Q13547 | HDAC1 | Histone deacetylase 1 | P19875 | CXCL2 | C-X-C motif chemokine 2 | -0.862 | P0DP23 | CALM1 | Calmodulin-1 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.729 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | P47992 | XCL1 | Lymphotactin | -0.706 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | Q9UBD3 | XCL2 | Cytokine SCM-1 beta | -0.706 | P0DP23 | CALM1 | Calmodulin-1 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.729 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P09769 | FGR | Tyrosine-protein kinase Fgr | 0.796 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | P07948 | LYN | Tyrosine-protein kinase Lyn | 0.707 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P07948 | LYN | Tyrosine-protein kinase Lyn | 0.971 | Q13547 | HDAC1 | Histone deacetylase 1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.774 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.777 | P0DP23 | CALM1 | Calmodulin-1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.744 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.766 | P0DP23 | CALM1 | Calmodulin-1 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.853 | Q13547 | HDAC1 | Histone deacetylase 1 | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | -0.864 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.727 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.941 | Q13547 | HDAC1 | Histone deacetylase 1 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.716 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.743 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.948 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P43250 | GRK6 | G protein-coupled receptor kinase 6 | 0.818 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | P49407 | ARRB1 | Beta-arrestin-1 | -0.721 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | -0.736 | P0DP23 | CALM1 | Calmodulin-1 | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.725 | P0DP23 | CALM1 | Calmodulin-1 | P51828 | ADCY7 | Adenylate cyclase type 7 | 0.719 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q7LDG7 | RASGRP2 | RAS guanyl-releasing protein 2 | 0.704 | P0DP23 | CALM1 | Calmodulin-1 | Q13009 | TIAM1 | Rho guanine nucleotide exchange factor TIAM1 | -0.788 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13009 | TIAM1 | Rho guanine nucleotide exchange factor TIAM1 | 0.706 | P0DP23 | CALM1 | Calmodulin-1 | P14598 | NCF1 | Neutrophil cytosol factor 1 | 0.854 | P0DP23 | CALM1 | Calmodulin-1 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.775 | P0DP23 | CALM1 | Calmodulin-1 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 0.761 | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.823 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q8WYR1 | PIK3R5 | Phosphoinositide 3-kinase regulatory subunit 5 | 0.752 |
| Pimozide | hsa04064 | NF-kappa B signaling pathway | 1.00E-09 | 25 | P10415, Q13489, P51617, O00463, Q13546, P14778, P01584, P01375, P29965, P19174, Q04759, Q9UDY8, Q13077, Q16548, P06239, Q8WV28, Q13315, P24522, O75293, Q8NHW4, P09341, P19875, Q06643, Q9UNE0, Q9NQC7 | BCL2, BIRC3, IRAK1, TRAF5, RIPK1, IL1R1, IL1B, TNF, CD40LG, PLCG1, PRKCQ, MALT1, TRAF1, BCL2A1, LCK, BLNK, ATM, GADD45A, GADD45B, CCL4L2, CXCL1, CXCL2, LTB, EDAR, CYLD | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P0DP23 | CALM1 | Calmodulin-1 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.772 | P17252 | PRKCA | Protein kinase C alpha type | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.844 | P0DP25 | CALM3 | Calmodulin-3 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.772 | P0DP24 | CALM2 | Calmodulin-2 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.772 | P0DP23 | CALM1 | Calmodulin-1 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.8 | P17252 | PRKCA | Protein kinase C alpha type | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.849 | P08235 | NR3C2 | Mineralocorticoid receptor | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.868 | P0DP25 | CALM3 | Calmodulin-3 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.8 | P0DP24 | CALM2 | Calmodulin-2 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.8 | P0DP23 | CALM1 | Calmodulin-1 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | -0.703 | P0DP25 | CALM3 | Calmodulin-3 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | -0.703 | P0DP24 | CALM2 | Calmodulin-2 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | -0.703 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.932 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.837 | P08235 | NR3C2 | Mineralocorticoid receptor | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | -0.749 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.766 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.76 | Q13547 | HDAC1 | Histone deacetylase 1 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.854 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P01584 | IL1B | Interleukin-1 beta | 0.807 | P0DP24 | CALM2 | Calmodulin-2 | P01584 | IL1B | Interleukin-1 beta | 0.72 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P01375 | TNF | Tumor necrosis factor | 0.78 | P0DP23 | CALM1 | Calmodulin-1 | P29965 | CD40LG | CD40 ligand | -0.721 | P17252 | PRKCA | Protein kinase C alpha type | P29965 | CD40LG | CD40 ligand | 0.788 | P0DP25 | CALM3 | Calmodulin-3 | P29965 | CD40LG | CD40 ligand | -0.721 | P0DP24 | CALM2 | Calmodulin-2 | P29965 | CD40LG | CD40 ligand | -0.721 | P0DP23 | CALM1 | Calmodulin-1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.744 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | P0DP25 | CALM3 | Calmodulin-3 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.744 | P0DP24 | CALM2 | Calmodulin-2 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.744 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q04759 | PRKCQ | Protein kinase C theta type | -0.767 | Q13547 | HDAC1 | Histone deacetylase 1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.723 | P17252 | PRKCA | Protein kinase C alpha type | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.769 | P08235 | NR3C2 | Mineralocorticoid receptor | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.708 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.796 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.73 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.958 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.875 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P06239 | LCK | Tyrosine-protein kinase Lck | -0.726 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | P17252 | PRKCA | Protein kinase C alpha type | Q8WV28 | BLNK | B-cell linker protein | 0.838 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q8WV28 | BLNK | B-cell linker protein | -0.704 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q8WV28 | BLNK | B-cell linker protein | -0.816 | P17252 | PRKCA | Protein kinase C alpha type | Q13315 | ATM | Serine-protein kinase ATM | 0.739 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.819 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.796 | P0DP23 | CALM1 | Calmodulin-1 | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.853 | P0DP25 | CALM3 | Calmodulin-3 | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.853 | P0DP24 | CALM2 | Calmodulin-2 | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.853 | P0DP23 | CALM1 | Calmodulin-1 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.729 | P0DP23 | CALM1 | Calmodulin-1 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.729 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P09341 | CXCL1 | Growth-regulated alpha protein | 0.788 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P09341 | CXCL1 | Growth-regulated alpha protein | 0.7 | Q13547 | HDAC1 | Histone deacetylase 1 | P09341 | CXCL1 | Growth-regulated alpha protein | -0.736 | Q13547 | HDAC1 | Histone deacetylase 1 | P19875 | CXCL2 | C-X-C motif chemokine 2 | -0.862 | Q13547 | HDAC1 | Histone deacetylase 1 | Q06643 | LTB | Lymphotoxin-beta | 0.74 | P08235 | NR3C2 | Mineralocorticoid receptor | Q9UNE0 | EDAR | Tumor necrosis factor receptor superfamily member EDAR | 0.819 | P0DP23 | CALM1 | Calmodulin-1 | Q9NQC7 | CYLD | Ubiquitin carboxyl-terminal hydrolase CYLD | 0.883 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q9NQC7 | CYLD | Ubiquitin carboxyl-terminal hydrolase CYLD | 0.799 | P0DP24 | CALM2 | Calmodulin-2 | Q9NQC7 | CYLD | Ubiquitin carboxyl-terminal hydrolase CYLD | 0.778 |
| Pimozide | hsa04066 | HIF-1 signaling pathway | 2.16E-02 | 1 | P08069 | IGF1R | More | | Pimozide | hsa04068 | FoxO signaling pathway | 3.80E-04 | 2 | P04049, P08069 | RAF1, IGF1R | More | | Pimozide | hsa04070 | Phosphatidylinositol signaling system | 7.01E-06 | 9 | P19174, P0DP23, Q14643, P23743, Q86XP1, P48426, P27987, Q96DU7, P17252 | PLCG1, CALM1, ITPR1, DGKA, DGKH, PIP4K2A, ITPKB, ITPKC, PRKCA | More | | Pimozide | hsa04071 | Sphingolipid signaling pathway | 2.29E-07 | 14 | P04049, P17252, P21453, Q9H228, P01375, Q13510, Q13362, Q16537, Q9BX95, Q16539, P04637, P10415, Q9UQC2, P01042 | RAF1, PRKCA, S1PR1, EDG8, TNF, ASAH1, PPP2R5C, PPP2R5E, SGPP1, MAPK14, TP53, BCL2, GAB2, KNG1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 | P17252 | PRKCA | Protein kinase C alpha type | P17252 | PRKCA | Protein kinase C alpha type | 1 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P17252 | PRKCA | Protein kinase C alpha type | 0.807 | P0DP24 | CALM2 | Calmodulin-2 | P17252 | PRKCA | Protein kinase C alpha type | -0.776 | P07550 | ADRB2 | Beta-2 adrenergic receptor | P21453 | S1PR1 | Sphingosine 1-phosphate receptor 1 | 0.704 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | -0.901 | P07550 | ADRB2 | Beta-2 adrenergic receptor | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | 0.809 | P08183 | ABCB1 | ATP-dependent translocase ABCB1 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | 0.787 | P14780 | MMP9 | Matrix metalloproteinase-9 | P01375 | TNF | Tumor necrosis factor | 0.897 | P07550 | ADRB2 | Beta-2 adrenergic receptor | P01375 | TNF | Tumor necrosis factor | -0.755 | P08183 | ABCB1 | ATP-dependent translocase ABCB1 | P01375 | TNF | Tumor necrosis factor | -0.769 | P0DP24 | CALM2 | Calmodulin-2 | Q13510 | ASAH1 | Acid ceramidase | 0.889 | P17252 | PRKCA | Protein kinase C alpha type | Q13362 | PPP2R5C | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform | 0.745 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q13362 | PPP2R5C | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform | -0.828 | P07550 | ADRB2 | Beta-2 adrenergic receptor | Q13362 | PPP2R5C | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform | 0.712 | P0DP24 | CALM2 | Calmodulin-2 | Q13362 | PPP2R5C | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform | 0.765 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | Q16537 | PPP2R5E | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform | 0.718 | P17252 | PRKCA | Protein kinase C alpha type | Q9BX95 | SGPP1 | Sphingosine-1-phosphate phosphatase 1 | 0.816 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | Q9BX95 | SGPP1 | Sphingosine-1-phosphate phosphatase 1 | 0.884 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q9BX95 | SGPP1 | Sphingosine-1-phosphate phosphatase 1 | -0.869 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.778 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P04637 | TP53 | Cellular tumor antigen p53 | 0.753 | P17252 | PRKCA | Protein kinase C alpha type | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.844 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.859 | P14780 | MMP9 | Matrix metalloproteinase-9 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.765 | P0DP24 | CALM2 | Calmodulin-2 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.772 | P08183 | ABCB1 | ATP-dependent translocase ABCB1 | Q9UQC2 | GAB2 | GRB2-associated-binding protein 2 | -0.866 | P0DP24 | CALM2 | Calmodulin-2 | Q9UQC2 | GAB2 | GRB2-associated-binding protein 2 | 0.798 | P0DP24 | CALM2 | Calmodulin-2 | P01042 | KNG1 | Kininogen-1 | -0.71 |
| Pimozide | hsa04072 | Phospholipase D signaling pathway | 1.52E-03 | 13 | P04049, P31751, P42338, P43657, P25024, P25025, P19174, P17252, Q15438, Q08828, P51828, P23743, P00734 | RAF1, AKT2, PIK3CB, P2RY5, CXCR1, CXCR2, PLCG1, PRKCA, PSCD1, ADCY1, ADCY7, DGKA, F2 | More | | Pimozide | hsa04080 | Neuroactive ligand-receptor interaction | 2.95E-04 | 8 | P08311, P28472, Q15722, P21453, Q9H228, O00398, P21730, P07550 | CTSG, GABRB3, LTB4R, S1PR1, EDG8, P2RY10, C5AR1, ADRB2 | More | | Pimozide | hsa04110 | Cell cycle | 4.61E-04 | 8 | Q9UBD5, P06493, Q14683, O75293, P30304, P33981, P42773, P01106 | ORC3, CDK1, SMC1A, GADD45B, CDC25A, TTK, CDKN2C, MYC | More | | Pimozide | hsa04114 | Oocyte meiosis | 4.41E-03 | 6 | Q9Y6D9, P51812, Q02750, P16298, Q17RY0, P08069 | MAD1L1, RPS6KA3, MAP2K1, PPP3CB, CPEB4, IGF1R | More | | Pimozide | hsa04120 | Ubiquitin mediated proteolysis | 2.51E-03 | 6 | Q14145, Q13042, P62837, Q15751, O95071, P0CG47 | KEAP1, CDC16, UBE2D2, HERC1, UBR5, UBB | More | | Pimozide | hsa04137 | Mitophagy - animal | 9.52E-03 | 2 | Q07817, P0CG47 | BCL2L1, UBB | More | | Pimozide | hsa04140 | Autophagy - animal | 1.37E-03 | 11 | P08069, P31751, P04049, Q7L523, Q96RR4, O75460, P22694, Q14643, P10415, Q96GC9, Q8TEV9 | IGF1R, AKT2, RAF1, RRAGA, CAMKK2, ERN1, PRKACB, ITPR1, BCL2, TMEM49, SMCR8 | More | | Pimozide | hsa04141 | Protein processing in endoplasmic reticulum | 2.01E-03 | 8 | P07384, O95487, Q99941, O75460, P11142, Q9H3Z4, P07900, O95816 | CAPN1, SEC24B, CREBL1, ERN1, HSPA8, DNAJC5, HSP90AA1, BAG2 | More | | Pimozide | hsa04142 | Lysosome | 2.64E-02 | 2 | Q99437, P25774 | ATP6V0B, CTSS | More | | Pimozide | hsa04144 | Endocytosis | 8.55E-04 | 15 | Q13191, P11142, Q9H444, O43633, O75351, Q9NZZ3, P25024, P43250, Q15438, Q14161, P14784, Q96QK1, Q9UMY4, Q9Y5X3, Q9UNH7 | CBLB, HSPA8, CHMP4B, CHMP2A, VPS4B, CHMP5, CXCR1, GRK6, PSCD1, GIT2, IL2RB, VPS35, SNX12, SNX5, SNX6 | More | | Pimozide | hsa04145 | Phagosome | 1.96E-10 | 14 | P60709, P63261, Q15075, Q15080, P14598, Q13509, P68371, Q13488, Q99437, P05164, O60603, P35443, P13765, P25774 | ACTB, ACTG1, EEA1, NCF4, NCF1, TUBB3, TUBB2C, TCIRG1, ATP6V0B, MPO, TLR2, THBS4, HLA-DOB, CTSS | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P29350 | PTPN6 | Tyrosine-protein phosphatase non-receptor type 6 | P60709 | ACTB | Actin, cytoplasmic 1 | 0.837 | P60660 | MYL6 | Myosin light polypeptide 6 | P60709 | ACTB | Actin, cytoplasmic 1 | 0.723 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P63261 | ACTG1 | Actin, cytoplasmic 2 | 0.719 | P60660 | MYL6 | Myosin light polypeptide 6 | P63261 | ACTG1 | Actin, cytoplasmic 2 | 0.723 | P29350 | PTPN6 | Tyrosine-protein phosphatase non-receptor type 6 | Q15075 | EEA1 | Early endosome antigen 1 | -0.821 | O15182 | CETN3 | Centrin-3 | Q15075 | EEA1 | Early endosome antigen 1 | 0.752 | P29350 | PTPN6 | Tyrosine-protein phosphatase non-receptor type 6 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.752 | P17252 | PRKCA | Protein kinase C alpha type | Q15080 | NCF4 | Neutrophil cytosol factor 4 | -0.836 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | Q15080 | NCF4 | Neutrophil cytosol factor 4 | -0.89 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | -0.951 | O15182 | CETN3 | Centrin-3 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | -0.715 | P29350 | PTPN6 | Tyrosine-protein phosphatase non-receptor type 6 | P14598 | NCF1 | Neutrophil cytosol factor 1 | 0.818 | P17252 | PRKCA | Protein kinase C alpha type | P14598 | NCF1 | Neutrophil cytosol factor 1 | -0.821 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P14598 | NCF1 | Neutrophil cytosol factor 1 | -0.708 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P14598 | NCF1 | Neutrophil cytosol factor 1 | -0.844 | O15182 | CETN3 | Centrin-3 | P14598 | NCF1 | Neutrophil cytosol factor 1 | -0.848 | P29350 | PTPN6 | Tyrosine-protein phosphatase non-receptor type 6 | Q13509 | TUBB3 | Tubulin beta-3 chain | 0.707 | P17252 | PRKCA | Protein kinase C alpha type | Q13509 | TUBB3 | Tubulin beta-3 chain | -0.756 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | Q13509 | TUBB3 | Tubulin beta-3 chain | -0.782 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q13509 | TUBB3 | Tubulin beta-3 chain | -0.809 | O15182 | CETN3 | Centrin-3 | Q13509 | TUBB3 | Tubulin beta-3 chain | -0.737 | P17252 | PRKCA | Protein kinase C alpha type | P68371 | TUBB2C | Tubulin beta-4B chain | -0.842 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P68371 | TUBB2C | Tubulin beta-4B chain | -0.726 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P68371 | TUBB2C | Tubulin beta-4B chain | -0.766 | P29350 | PTPN6 | Tyrosine-protein phosphatase non-receptor type 6 | Q13488 | TCIRG1 | V-type proton ATPase 116 kDa subunit a 3 | 0.753 | P17252 | PRKCA | Protein kinase C alpha type | Q13488 | TCIRG1 | V-type proton ATPase 116 kDa subunit a 3 | -0.779 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q13488 | TCIRG1 | V-type proton ATPase 116 kDa subunit a 3 | -0.718 | O15182 | CETN3 | Centrin-3 | Q13488 | TCIRG1 | V-type proton ATPase 116 kDa subunit a 3 | -0.767 | P25774 | CTSS | Cathepsin S | Q99437 | ATP6V0B | V-type proton ATPase 21 kDa proteolipid subunit c'' | 0.722 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P05164 | MPO | Myeloperoxidase | -0.754 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P05164 | MPO | Myeloperoxidase | -0.81 | P17252 | PRKCA | Protein kinase C alpha type | O60603 | TLR2 | Toll-like receptor 2 | -0.716 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | O60603 | TLR2 | Toll-like receptor 2 | -0.797 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | O60603 | TLR2 | Toll-like receptor 2 | -0.884 | O15182 | CETN3 | Centrin-3 | O60603 | TLR2 | Toll-like receptor 2 | -0.725 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P35443 | THBS4 | Thrombospondin-4 | -0.744 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P35443 | THBS4 | Thrombospondin-4 | -0.765 | P17252 | PRKCA | Protein kinase C alpha type | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.709 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.75 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.754 | P25774 | CTSS | Cathepsin S | P25774 | CTSS | Cathepsin S | 1 |
| Pimozide | hsa04150 | mTOR signaling pathway | 5.20E-04 | 2 | P08069, P04049 | IGF1R, RAF1 | More | | Pimozide | hsa04151 | PI3K-Akt signaling pathway | 8.96E-07 | 33 | P62753, P42338, P43657, P25116, O43521, P27348, P09603, P20827, P49767, Q9GZP0, Q13362, P08238, Q8WYR1, P62873, P63218, P50151, P13612, P16144, O15335, Q13751, O60603, P48551, P14784, P23458, P01568, P15336, P18848, P10415, P17252, Q16513, O00141, Q6ZUJ8, P30281 | RPS6, PIK3CB, P2RY5, F2R, BCL2L11, YWHAQ, CSF1, EFNA1, VEGFC, PDGFD, PPP2R5C, HSP90AB1, PIK3R5, GNB1, GNG5, GNG10, ITGA4, ITGB4, CHAD, LAMB3, TLR2, IFNAR2, IL2RB, JAK1, IFNA21, ATF2, ATF4, BCL2, PRKCA, PKN2, SGK, PIK3AP1, CCND3 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P62753 | RPS6 | 40S ribosomal protein S6 | 0.709 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.777 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | 0.702 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | -0.735 | P17252 | PRKCA | Protein kinase C alpha type | P25116 | F2R | Proteinase-activated receptor 1 | 0.857 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | O43521 | BCL2L11 | Bcl-2-like protein 11 | 0.724 | P0DP24 | CALM2 | Calmodulin-2 | O43521 | BCL2L11 | Bcl-2-like protein 11 | 0.75 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P27348 | YWHAQ | 14-3-3 protein theta | 0.708 | P0DP24 | CALM2 | Calmodulin-2 | P27348 | YWHAQ | 14-3-3 protein theta | 0.777 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | P09603 | CSF1 | Macrophage colony-stimulating factor 1 | -0.789 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P20827 | EFNA1 | Ephrin-A1 | 0.715 | P0DP24 | CALM2 | Calmodulin-2 | P20827 | EFNA1 | Ephrin-A1 | -0.795 | P17252 | PRKCA | Protein kinase C alpha type | P49767 | VEGFC | Vascular endothelial growth factor C | 0.719 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P49767 | VEGFC | Vascular endothelial growth factor C | 0.743 | P0DP24 | CALM2 | Calmodulin-2 | P49767 | VEGFC | Vascular endothelial growth factor C | -0.84 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | Q9GZP0 | PDGFD | Platelet-derived growth factor D | 0.736 | P17252 | PRKCA | Protein kinase C alpha type | Q13362 | PPP2R5C | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform | 0.745 | P0DP24 | CALM2 | Calmodulin-2 | Q13362 | PPP2R5C | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform | 0.765 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.823 | P0DP24 | CALM2 | Calmodulin-2 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.775 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | Q8WYR1 | PIK3R5 | Phosphoinositide 3-kinase regulatory subunit 5 | 0.76 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q8WYR1 | PIK3R5 | Phosphoinositide 3-kinase regulatory subunit 5 | 0.752 | P17252 | PRKCA | Protein kinase C alpha type | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.852 | P0DP24 | CALM2 | Calmodulin-2 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.853 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | -0.844 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.941 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.902 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.948 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | P13612 | ITGA4 | Integrin alpha-4 | 0.77 | P17252 | PRKCA | Protein kinase C alpha type | P16144 | ITGB4 | Integrin beta-4 | 0.755 | P0DP24 | CALM2 | Calmodulin-2 | P16144 | ITGB4 | Integrin beta-4 | -0.725 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | O15335 | CHAD | Chondroadherin | -0.729 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O15335 | CHAD | Chondroadherin | 0.795 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | Q13751 | LAMB3 | Laminin subunit beta-3 | -0.794 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13751 | LAMB3 | Laminin subunit beta-3 | 0.844 | P17252 | PRKCA | Protein kinase C alpha type | O60603 | TLR2 | Toll-like receptor 2 | -0.716 | P60660 | MYL6 | Myosin light polypeptide 6 | P48551 | IFNAR2 | Interferon alpha/beta receptor 2 | 0.746 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.835 | P0DP24 | CALM2 | Calmodulin-2 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.801 | P0DP24 | CALM2 | Calmodulin-2 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.738 | P17252 | PRKCA | Protein kinase C alpha type | P01568 | IFNA21 | Interferon alpha-21 | 0.733 | P0DP24 | CALM2 | Calmodulin-2 | P01568 | IFNA21 | Interferon alpha-21 | -0.852 | P60660 | MYL6 | Myosin light polypeptide 6 | P15336 | ATF2 | Cyclic AMP-dependent transcription factor ATF-2 | 0.729 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.723 | P0DP24 | CALM2 | Calmodulin-2 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.708 | P17252 | PRKCA | Protein kinase C alpha type | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.844 | P0DP24 | CALM2 | Calmodulin-2 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.772 | P17252 | PRKCA | Protein kinase C alpha type | P17252 | PRKCA | Protein kinase C alpha type | 1 | P0DP24 | CALM2 | Calmodulin-2 | P17252 | PRKCA | Protein kinase C alpha type | -0.776 | P60660 | MYL6 | Myosin light polypeptide 6 | Q16513 | PKN2 | Serine/threonine-protein kinase N2 | -0.748 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | O00141 | SGK | Serine/threonine-protein kinase Sgk1 | 0.755 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | Q6ZUJ8 | PIK3AP1 | Phosphoinositide 3-kinase adapter protein 1 | 0.728 | P0DP24 | CALM2 | Calmodulin-2 | Q6ZUJ8 | PIK3AP1 | Phosphoinositide 3-kinase adapter protein 1 | 0.859 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P30281 | CCND3 | G1/S-specific cyclin-D3 | 0.743 |
| Pimozide | hsa04152 | AMPK signaling pathway | 1.99E-02 | 1 | P08069 | IGF1R | More | | Pimozide | hsa04210 | Apoptosis | 2.75E-05 | 11 | O76075, P07384, P01375, Q9NR28, O75460, Q16548, O43521, P18848, P60709, P63261, P04049 | DFFB, CAPN1, TNF, DIABLO, ERN1, BCL2A1, BCL2L11, ATF4, ACTB, ACTG1, RAF1 | More | | Pimozide | hsa04211 | Longevity regulating pathway | 1.34E-03 | 4 | Q12778, P08069, Q9UEF7, Q96KQ7 | FOXO1, IGF1R, KL, EHMT2 | More | | Pimozide | hsa04213 | Longevity regulating pathway - multiple species | 1.17E-02 | 5 | P42338, P08069, Q9Y4H2, P11142, Q13547 | PIK3CB, IGF1R, IRS2, HSPA8, HDAC1 | More | | Pimozide | hsa04217 | Necroptosis | 3.59E-13 | 23 | P01375, P01568, P23458, P48023, Q13489, Q9NQC7, Q13546, P42224, Q14765, P08238, P15104, P05141, P01584, P0C0S5, Q6FI13, Q99878, P10415, Q13557, Q9H444, O43633, Q9NZZ3, O75351, Q08752 | TNF, IFNA21, JAK1, FASLG, BIRC3, CYLD, RIPK1, STAT1, STAT4, HSP90AB1, GLUL, SLC25A5, IL1B, H2AFZ, H2AC18; H2AC19, H2AC14, BCL2, CAMK2D, CHMP4B, CHMP2A, CHMP5, VPS4B, PPID | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P14416 | DRD2 | D(2) dopamine receptor | P01375 | TNF | Tumor necrosis factor | -0.767 | P0DP23 | CALM1 | Calmodulin-1 | P01568 | IFNA21 | Interferon alpha-21 | -0.852 | P17252 | PRKCA | Protein kinase C alpha type | P01568 | IFNA21 | Interferon alpha-21 | 0.733 | P08235 | NR3C2 | Mineralocorticoid receptor | P01568 | IFNA21 | Interferon alpha-21 | 0.757 | P0DP25 | CALM3 | Calmodulin-3 | P01568 | IFNA21 | Interferon alpha-21 | -0.852 | P0DP24 | CALM2 | Calmodulin-2 | P01568 | IFNA21 | Interferon alpha-21 | -0.852 | P0DP23 | CALM1 | Calmodulin-1 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.822 | P0DP24 | CALM2 | Calmodulin-2 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.738 | P14416 | DRD2 | D(2) dopamine receptor | P48023 | FASLG | Tumor necrosis factor ligand superfamily member 6 | 0.7 | P0DP23 | CALM1 | Calmodulin-1 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.8 | P17252 | PRKCA | Protein kinase C alpha type | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.849 | P08235 | NR3C2 | Mineralocorticoid receptor | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.868 | P0DP25 | CALM3 | Calmodulin-3 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.8 | P0DP24 | CALM2 | Calmodulin-2 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.8 | P0DP23 | CALM1 | Calmodulin-1 | Q9NQC7 | CYLD | Ubiquitin carboxyl-terminal hydrolase CYLD | 0.883 | P0DP24 | CALM2 | Calmodulin-2 | Q9NQC7 | CYLD | Ubiquitin carboxyl-terminal hydrolase CYLD | 0.778 | P08235 | NR3C2 | Mineralocorticoid receptor | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | -0.749 | P0DP23 | CALM1 | Calmodulin-1 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.775 | P17252 | PRKCA | Protein kinase C alpha type | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | -0.706 | P0DP25 | CALM3 | Calmodulin-3 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.775 | P0DP24 | CALM2 | Calmodulin-2 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.775 | P14416 | DRD2 | D(2) dopamine receptor | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | 0.71 | P0DP23 | CALM1 | Calmodulin-1 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.775 | P0DP25 | CALM3 | Calmodulin-3 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.775 | P0DP24 | CALM2 | Calmodulin-2 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.775 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P15104 | GLUL | Glutamine synthetase | 0.754 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.797 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P01584 | IL1B | Interleukin-1 beta | 0.825 | P0DP24 | CALM2 | Calmodulin-2 | P01584 | IL1B | Interleukin-1 beta | 0.72 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P0C0S5 | H2AFZ | Histone H2A.Z | 0.732 | P0DP24 | CALM2 | Calmodulin-2 | P0C0S5 | H2AFZ | Histone H2A.Z | 0.749 | P0DP23 | CALM1 | Calmodulin-1 | Q6FI13 | H2AC18; H2AC19 | Histone H2A type 2-A | 0.81 | P17252 | PRKCA | Protein kinase C alpha type | Q6FI13 | H2AC18; H2AC19 | Histone H2A type 2-A | -0.83 | P0DP25 | CALM3 | Calmodulin-3 | Q6FI13 | H2AC18; H2AC19 | Histone H2A type 2-A | 0.81 | P0DP24 | CALM2 | Calmodulin-2 | Q6FI13 | H2AC18; H2AC19 | Histone H2A type 2-A | 0.81 | P14416 | DRD2 | D(2) dopamine receptor | Q99878 | H2AC14 | Histone H2A type 1-J | -0.784 | P0DP23 | CALM1 | Calmodulin-1 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.772 | P17252 | PRKCA | Protein kinase C alpha type | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.844 | P0DP25 | CALM3 | Calmodulin-3 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.772 | P0DP24 | CALM2 | Calmodulin-2 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.772 | P0DP24 | CALM2 | Calmodulin-2 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | 0.786 | P0DP23 | CALM1 | Calmodulin-1 | Q9H444 | CHMP4B | Charged multivesicular body protein 4b | 0.73 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | Q9H444 | CHMP4B | Charged multivesicular body protein 4b | 0.731 | P0DP24 | CALM2 | Calmodulin-2 | Q9H444 | CHMP4B | Charged multivesicular body protein 4b | 0.713 | P0DP23 | CALM1 | Calmodulin-1 | O43633 | CHMP2A | Charged multivesicular body protein 2a | 0.842 | P17252 | PRKCA | Protein kinase C alpha type | O43633 | CHMP2A | Charged multivesicular body protein 2a | -0.836 | P0DP25 | CALM3 | Calmodulin-3 | O43633 | CHMP2A | Charged multivesicular body protein 2a | 0.842 | P0DP24 | CALM2 | Calmodulin-2 | O43633 | CHMP2A | Charged multivesicular body protein 2a | 0.842 | P0DP23 | CALM1 | Calmodulin-1 | Q9NZZ3 | CHMP5 | Charged multivesicular body protein 5 | 0.713 | P0DP24 | CALM2 | Calmodulin-2 | Q9NZZ3 | CHMP5 | Charged multivesicular body protein 5 | 0.763 | P0DP23 | CALM1 | Calmodulin-1 | O75351 | VPS4B | Vacuolar protein sorting-associated protein 4B | 0.784 | P17252 | PRKCA | Protein kinase C alpha type | Q08752 | PPID | Peptidyl-prolyl cis-trans isomerase D | 0.725 |
| Pimozide | hsa04218 | Cellular senescence | 8.08E-03 | 5 | P01106, P04049, O75293, P30304, P06493 | MYC, RAF1, GADD45B, CDC25A, CDK1 | More | | Pimozide | hsa04260 | Cardiac muscle contraction | 4.02E-02 | 2 | P09493, P14927 | TPM1, UQCRB | More | | Pimozide | hsa04261 | Adrenergic signaling in cardiomyocytes | 6.52E-09 | 14 | P09493, P07550, Q08828, P51828, P22694, P31751, Q99941, P18848, Q13362, P0DP23, Q13557, P17252, P10415, P23634 | TPM1, ADRB2, ADCY1, ADCY7, PRKACB, AKT2, CREBL1, ATF4, PPP2R5C, CALM1, CAMK2D, PRKCA, BCL2, ATP2B4 | More | | Pimozide | hsa04270 | Vascular smooth muscle contraction | 2.32E-02 | 1 | P04049 | RAF1 | More | | Pimozide | hsa04330 | Notch signaling pathway | 2.46E-03 | 3 | Q92542, P49768, P46531 | NCSTN, PSEN1, NOTCH1 | More | | Pimozide | hsa04340 | Hedgehog signaling pathway | 1.36E-04 | 4 | P49841, P22694, Q13635, P10415 | GSK3B, PRKACB, PTCH1, BCL2 | More | | Pimozide | hsa04360 | Axon guidance | 3.31E-06 | 12 | P61073, P16333, P20827, O95631, P17252, Q13557, P42338, P07332, P23528, P04049, P19174, Q06124 | CXCR4, NCK1, EFNA1, NTN1, PRKCA, CAMK2D, PIK3CB, FES, CFL1, RAF1, PLCG1, PTPN11 | More | | Pimozide | hsa04370 | VEGF signaling pathway | 9.75E-04 | 4 | P16298, Q05397, Q02750, P04049 | PPP3CB, PTK2, MAP2K1, RAF1 | More | | Pimozide | hsa04371 | Apelin signaling pathway | 5.57E-04 | 14 | P62873, P63218, P50151, Q8WYR1, P31751, P04049, Q08828, P51828, Q13370, Q14814, Q14344, Q13485, P84022, P0DP23 | GNB1, GNG5, GNG10, PIK3R5, AKT2, RAF1, ADCY1, ADCY7, PDE3B, MEF2D, GNA13, SMAD4, SMAD3, CALM1 | More | | Pimozide | hsa04380 | Osteoclast differentiation | 3.26E-04 | 14 | Q9NQC7, Q9UQC2, Q16539, P23458, P42224, P06239, P01584, P14778, O75015, Q8WV28, P01375, Q15080, P14598, P78324 | CYLD, GAB2, MAPK14, JAK1, STAT1, LCK, IL1B, IL1R1, FCGR3B, BLNK, TNF, NCF4, NCF1, SIRPA | More | | Pimozide | hsa04390 | Hippo signaling pathway | 2.63E-03 | 3 | P60709, P63261, O15105 | ACTB, ACTG1, SMAD7 | More | | Pimozide | hsa04392 | Hippo signaling pathway - multiple species | 3.01E-02 | 1 | Q6V0I7 | FAT4 | More | | Pimozide | hsa04510 | Focal adhesion | 3.91E-03 | 9 | P16144, O75369, Q15942, P17252, Q13489, P10415, P04049, P08069, P49767 | ITGB4, FLNB, ZYX, PRKCA, BIRC3, BCL2, RAF1, IGF1R, VEGFC | More | | Pimozide | hsa04512 | ECM-receptor interaction | 9.21E-03 | 4 | Q16787, Q13751, P13612, O15335 | LAMA3, LAMB3, ITGA4, CHAD | More | | Pimozide | hsa04520 | Adherens junction | 6.59E-04 | 3 | P08069, P60709, P63261 | IGF1R, ACTB, ACTG1 | More | | Pimozide | hsa04530 | Tight junction | 5.12E-06 | 8 | P60709, P63261, P16989, P56750, Q9Y478, Q92974, Q14247, P60660 | ACTB, ACTG1, CSDA, CLDN17, PRKAB1, ARHGEF2, CTTN, MYL6 | More | | Pimozide | hsa04540 | Gap junction | 5.12E-06 | 8 | P17252, P22694, Q13509, P68371, Q08828, P51828, P04049, Q14643 | PRKCA, PRKACB, TUBB3, TUBB2C, ADCY1, ADCY7, RAF1, ITPR1 | More | | Pimozide | hsa04550 | Signaling pathways regulating pluripotency of stem cells | 3.80E-04 | 2 | P04049, P08069 | RAF1, IGF1R | More | | Pimozide | hsa04610 | Complement and coagulation cascades | 1.01E-04 | 1 | P0C0L4 | C4A | More | | Pimozide | hsa04611 | Platelet activation | 2.61E-02 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Pimozide | hsa04612 | Antigen processing and presentation | 7.40E-07 | 9 | P13765, P48382, Q14953, P26715, P26717, Q13241, O43908, P01732, P01375 | HLA-DOB, RFX5, KIR2DS5, KLRC1, KLRC2, KLRD1, KLRC4, CD8A, TNF | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P14780 | MMP9 | Matrix metalloproteinase-9 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.714 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.7 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.73 | P14780 | MMP9 | Matrix metalloproteinase-9 | P48382 | RFX5 | DNA-binding protein RFX5 | -0.874 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | P48382 | RFX5 | DNA-binding protein RFX5 | -0.743 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P48382 | RFX5 | DNA-binding protein RFX5 | -0.738 | P07550 | ADRB2 | Beta-2 adrenergic receptor | Q14953 | KIR2DS5 | Killer cell immunoglobulin-like receptor 2DS5 | 0.815 | P14780 | MMP9 | Matrix metalloproteinase-9 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.867 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.714 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.838 | P07550 | ADRB2 | Beta-2 adrenergic receptor | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.72 | P14780 | MMP9 | Matrix metalloproteinase-9 | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.867 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.714 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.838 | P07550 | ADRB2 | Beta-2 adrenergic receptor | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.72 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.837 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.715 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.856 | P07550 | ADRB2 | Beta-2 adrenergic receptor | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.838 | P14780 | MMP9 | Matrix metalloproteinase-9 | O43908 | KLRC4 | NKG2-F type II integral membrane protein | -0.792 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | O43908 | KLRC4 | NKG2-F type II integral membrane protein | -0.721 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | O43908 | KLRC4 | NKG2-F type II integral membrane protein | -0.741 | P14780 | MMP9 | Matrix metalloproteinase-9 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.742 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.722 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.816 | P07550 | ADRB2 | Beta-2 adrenergic receptor | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.812 | P14780 | MMP9 | Matrix metalloproteinase-9 | P01375 | TNF | Tumor necrosis factor | 0.897 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P01375 | TNF | Tumor necrosis factor | 0.774 | P07550 | ADRB2 | Beta-2 adrenergic receptor | P01375 | TNF | Tumor necrosis factor | -0.755 |
| Pimozide | hsa04613 | Neutrophil extracellular trap formation | 2.91E-09 | 26 | P17252, P04049, P11215, O60603, P05164, P08246, Q9UM07, Q13547, Q92769, P04908, P0C0S5, Q6FI13, Q93077, P62807, O60814, P68431, P14598, Q15080, P20160, P08311, O75015, P21730, P21462, P63261, O43315, Q16539 | PRKCA, RAF1, ITGAM, TLR2, MPO, ELA2, PADI4, HDAC1, HDAC2, H2AC4; H2AC8, H2AFZ, H2AC18; H2AC19, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, NCF1, NCF4, AZU1, CTSG, FCGR3B, C5AR1, FPR1, ACTG1, AQP9, MAPK14 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P17252 | PRKCA | Protein kinase C alpha type | P17252 | PRKCA | Protein kinase C alpha type | 1 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P17252 | PRKCA | Protein kinase C alpha type | 0.807 | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 | Q99527 | GPER1 | G-protein coupled estrogen receptor 1 | P11215 | ITGAM | Integrin alpha-M | 0.734 | P17252 | PRKCA | Protein kinase C alpha type | O60603 | TLR2 | Toll-like receptor 2 | -0.716 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | O60603 | TLR2 | Toll-like receptor 2 | -0.797 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | O60603 | TLR2 | Toll-like receptor 2 | 0.842 | P14780 | MMP9 | Matrix metalloproteinase-9 | O60603 | TLR2 | Toll-like receptor 2 | 0.89 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | O60603 | TLR2 | Toll-like receptor 2 | 0.867 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P05164 | MPO | Myeloperoxidase | -0.754 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P05164 | MPO | Myeloperoxidase | 0.719 | P14780 | MMP9 | Matrix metalloproteinase-9 | P05164 | MPO | Myeloperoxidase | 0.812 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P05164 | MPO | Myeloperoxidase | 0.711 | P17252 | PRKCA | Protein kinase C alpha type | P08246 | ELA2 | Neutrophil elastase | -0.735 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P08246 | ELA2 | Neutrophil elastase | -0.833 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P08246 | ELA2 | Neutrophil elastase | 0.702 | P14780 | MMP9 | Matrix metalloproteinase-9 | P08246 | ELA2 | Neutrophil elastase | 0.859 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P08246 | ELA2 | Neutrophil elastase | 0.703 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | -0.771 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | 0.813 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | 0.9 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | 0.825 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q13547 | HDAC1 | Histone deacetylase 1 | -0.7 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q13547 | HDAC1 | Histone deacetylase 1 | -0.742 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q92769 | HDAC2 | Histone deacetylase 2 | -0.7 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q92769 | HDAC2 | Histone deacetylase 2 | -0.746 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | P04908 | H2AC4; H2AC8 | Histone H2A type 1-B/E | 0.734 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P0C0S5 | H2AFZ | Histone H2A.Z | 0.785 | P17252 | PRKCA | Protein kinase C alpha type | Q6FI13 | H2AC18; H2AC19 | Histone H2A type 2-A | -0.83 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | Q6FI13 | H2AC18; H2AC19 | Histone H2A type 2-A | -0.859 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q6FI13 | H2AC18; H2AC19 | Histone H2A type 2-A | 0.74 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q93077 | HIST1H2AC | Histone H2A type 1-C | 0.737 | P11712 | CYP2C9 | Cytochrome P450 2C9 | Q93077 | HIST1H2AC | Histone H2A type 1-C | 0.754 | Q99527 | GPER1 | G-protein coupled estrogen receptor 1 | P62807 | HIST1H2BC | Histone H2B type 1-C/E/F/G/I | 0.753 | P11712 | CYP2C9 | Cytochrome P450 2C9 | P62807 | HIST1H2BC | Histone H2B type 1-C/E/F/G/I | 0.717 | Q99527 | GPER1 | G-protein coupled estrogen receptor 1 | P62807 | HIST1H2BC | Histone H2B type 1-C/E/F/G/I | 0.753 | P11712 | CYP2C9 | Cytochrome P450 2C9 | P62807 | HIST1H2BC | Histone H2B type 1-C/E/F/G/I | 0.717 | Q99527 | GPER1 | G-protein coupled estrogen receptor 1 | O60814 | H2BC12 | Histone H2B type 1-K | 0.793 | P11712 | CYP2C9 | Cytochrome P450 2C9 | O60814 | H2BC12 | Histone H2B type 1-K | 0.728 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | P68431 | H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | Histone H3.1 | 0.913 | P17252 | PRKCA | Protein kinase C alpha type | P68431 | H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | Histone H3.1 | 0.783 | P11712 | CYP2C9 | Cytochrome P450 2C9 | P68431 | H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | Histone H3.1 | 0.845 | P17252 | PRKCA | Protein kinase C alpha type | P14598 | NCF1 | Neutrophil cytosol factor 1 | -0.821 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P14598 | NCF1 | Neutrophil cytosol factor 1 | -0.708 | P17252 | PRKCA | Protein kinase C alpha type | Q15080 | NCF4 | Neutrophil cytosol factor 4 | -0.836 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | Q15080 | NCF4 | Neutrophil cytosol factor 4 | -0.89 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.762 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.869 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.764 | P14780 | MMP9 | Matrix metalloproteinase-9 | P20160 | AZU1 | Azurocidin | 0.734 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P08311 | CTSG | Cathepsin G | 0.744 | P14780 | MMP9 | Matrix metalloproteinase-9 | P08311 | CTSG | Cathepsin G | 0.79 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P08311 | CTSG | Cathepsin G | 0.709 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.92 | P14780 | MMP9 | Matrix metalloproteinase-9 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.928 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.893 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | 0.983 | P14780 | MMP9 | Matrix metalloproteinase-9 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | 0.942 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | 1 | P17252 | PRKCA | Protein kinase C alpha type | P21462 | FPR1 | fMet-Leu-Phe receptor | -0.731 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P21462 | FPR1 | fMet-Leu-Phe receptor | -0.723 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P21462 | FPR1 | fMet-Leu-Phe receptor | 0.839 | P14780 | MMP9 | Matrix metalloproteinase-9 | P21462 | FPR1 | fMet-Leu-Phe receptor | 0.912 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P21462 | FPR1 | fMet-Leu-Phe receptor | 0.842 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P63261 | ACTG1 | Actin, cytoplasmic 2 | 0.719 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | O43315 | AQP9 | Aquaporin-9 | -0.764 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | O43315 | AQP9 | Aquaporin-9 | 0.934 | P14780 | MMP9 | Matrix metalloproteinase-9 | O43315 | AQP9 | Aquaporin-9 | 0.837 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | O43315 | AQP9 | Aquaporin-9 | 0.915 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | -0.744 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.883 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.778 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.833 |
| Pimozide | hsa04614 | Renin-angiotensin system | 2.74E-02 | 3 | P15144, P08311, O75787 | ANPEP, CTSG, ATP6AP2 | More | | Pimozide | hsa04620 | Toll-like receptor signaling pathway | 2.13E-03 | 6 | P51617, Q13546, P01568, P31751, P42224, Q8NHW4 | IRAK1, RIPK1, IFNA21, AKT2, STAT1, CCL4L2 | More | | Pimozide | hsa04621 | NOD-like receptor signaling pathway | 6.48E-04 | 19 | P01584, P08238, Q16539, Q14643, P23458, P42224, P01568, Q9H3M7, Q13489, P10599, Q9H1Y0, P43490, O00463, P10415, Q13546, Q05823, P01375, P09341, P12838 | IL1B, HSP90AB1, MAPK14, ITPR1, JAK1, STAT1, IFNA21, TXNIP, BIRC3, TXN, ATG5, PBEF1, TRAF5, BCL2, RIPK1, RNASEL, TNF, CXCL1, DEFA4 | More | | Pimozide | hsa04622 | RIG-I-like receptor signaling pathway | 2.39E-02 | 2 | P01568, Q13546 | IFNA21, RIPK1 | More | | Pimozide | hsa04623 | Cytosolic DNA-sensing pathway | 7.83E-04 | 3 | P01568, Q13546, Q8NHW4 | IFNA21, RIPK1, CCL4L2 | More | | Pimozide | hsa04625 | C-type lectin receptor signaling pathway | 2.72E-04 | 10 | Q9ULY5, P04049, P01584, Q9NQC7, P20749, Q14643, P01375, Q13191, P0DP24, Q16539 | CLEC4E, RAF1, IL1B, CYLD, BCL3, ITPR1, TNF, CBLB, CALM2, MAPK14 | More | | Pimozide | hsa04630 | JAK-STAT signaling pathway | 1.77E-03 | 9 | P31751, P10415, P42224, P23458, P14784, P16871, Q13651, P04049, P01568 | AKT2, BCL2, STAT1, JAK1, IL2RB, IL7R, IL10RA, RAF1, IFNA21 | More | | Pimozide | hsa04640 | Hematopoietic cell lineage | 2.61E-06 | 17 | P13612, P08514, P21926, P14778, P27930, P11215, P15144, P11836, P25063, P07766, P09693, P01732, P01730, P09564, P13765, P01375, P01584 | ITGA4, ITGA2B, CD9, IL1R1, IL1R2, ITGAM, ANPEP, MS4A1, CD24, CD3E, CD3G, CD8A, CD4, CD7, HLA-DOB, TNF, IL1B | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P13612 | ITGA4 | Integrin alpha-4 | -0.797 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P13612 | ITGA4 | Integrin alpha-4 | -0.771 | P24844 | MYL9 | Myosin regulatory light polypeptide 9 | P08514 | ITGA2B | Integrin alpha-IIb | 0.81 | P52732 | KIF11 | Kinesin-like protein KIF11 | P21926 | CD9 | CD9 antigen | -0.787 | P24844 | MYL9 | Myosin regulatory light polypeptide 9 | P21926 | CD9 | CD9 antigen | 0.853 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.766 | Q13547 | HDAC1 | Histone deacetylase 1 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.854 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.762 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.926 | Q13547 | HDAC1 | Histone deacetylase 1 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | -0.837 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.924 | Q13547 | HDAC1 | Histone deacetylase 1 | P11215 | ITGAM | Integrin alpha-M | -0.751 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P15144 | ANPEP | Aminopeptidase N | 0.851 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P15144 | ANPEP | Aminopeptidase N | 0.879 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P11836 | MS4A1 | B-lymphocyte antigen CD20 | -0.71 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P11836 | MS4A1 | B-lymphocyte antigen CD20 | -0.705 | Q13547 | HDAC1 | Histone deacetylase 1 | P25063 | CD24 | Signal transducer CD24 | -0.706 | P52732 | KIF11 | Kinesin-like protein KIF11 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.724 | Q13547 | HDAC1 | Histone deacetylase 1 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.802 | P24844 | MYL9 | Myosin regulatory light polypeptide 9 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.703 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.835 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.815 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.781 | Q13547 | HDAC1 | Histone deacetylase 1 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.816 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.816 | P52732 | KIF11 | Kinesin-like protein KIF11 | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.719 | P52732 | KIF11 | Kinesin-like protein KIF11 | P09564 | CD7 | T-cell antigen CD7 | -0.886 | Q13547 | HDAC1 | Histone deacetylase 1 | P09564 | CD7 | T-cell antigen CD7 | 0.738 | P24844 | MYL9 | Myosin regulatory light polypeptide 9 | P09564 | CD7 | T-cell antigen CD7 | 0.759 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.785 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.73 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P01375 | TNF | Tumor necrosis factor | 0.78 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P01375 | TNF | Tumor necrosis factor | 0.774 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P01584 | IL1B | Interleukin-1 beta | 0.807 |
| Pimozide | hsa04650 | Natural killer cell mediated cytotoxicity | 9.83E-12 | 15 | P19174, P01375, P78314, P06239, O60880, P20963, P42338, P04049, Q13241, P26718, O14931, O75015, P26717, Q14953, P26715 | PLCG1, TNF, SH3BP2, LCK, SH2D1A, CD247, PIK3CB, RAF1, KLRD1, KLRK1, NCR3, FCGR3B, KLRC2, KIR2DS5, KLRC1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P01375 | TNF | Tumor necrosis factor | 0.78 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | P01375 | TNF | Tumor necrosis factor | 0.718 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P01375 | TNF | Tumor necrosis factor | 0.774 | P07550 | ADRB2 | Beta-2 adrenergic receptor | P01375 | TNF | Tumor necrosis factor | -0.755 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P78314 | SH3BP2 | SH3 domain-binding protein 2 | 0.761 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | P78314 | SH3BP2 | SH3 domain-binding protein 2 | 0.748 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P78314 | SH3BP2 | SH3 domain-binding protein 2 | 0.809 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P06239 | LCK | Tyrosine-protein kinase Lck | -0.726 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.779 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | O60880 | SH2D1A | SH2 domain-containing protein 1A | -0.823 | Q13547 | HDAC1 | Histone deacetylase 1 | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.786 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | O60880 | SH2D1A | SH2 domain-containing protein 1A | -0.751 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | O60880 | SH2D1A | SH2 domain-containing protein 1A | -0.788 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | O60880 | SH2D1A | SH2 domain-containing protein 1A | -0.81 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.786 | Q13547 | HDAC1 | Histone deacetylase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.87 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.722 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.771 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.77 | P07550 | ADRB2 | Beta-2 adrenergic receptor | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.727 | Q13547 | HDAC1 | Histone deacetylase 1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.774 | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.82 | Q13547 | HDAC1 | Histone deacetylase 1 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.807 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.715 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.701 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.856 | P07550 | ADRB2 | Beta-2 adrenergic receptor | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.838 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P26718 | KLRK1 | NKG2-D type II integral membrane protein | -0.91 | Q13547 | HDAC1 | Histone deacetylase 1 | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.772 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | P26718 | KLRK1 | NKG2-D type II integral membrane protein | -0.842 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | P26718 | KLRK1 | NKG2-D type II integral membrane protein | -0.81 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P26718 | KLRK1 | NKG2-D type II integral membrane protein | -0.879 | P07550 | ADRB2 | Beta-2 adrenergic receptor | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.701 | Q13547 | HDAC1 | Histone deacetylase 1 | O14931 | NCR3 | Natural cytotoxicity triggering receptor 3 | 0.735 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.92 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.913 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.896 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.893 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.846 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.714 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.721 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.838 | P07550 | ADRB2 | Beta-2 adrenergic receptor | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.72 | P07550 | ADRB2 | Beta-2 adrenergic receptor | Q14953 | KIR2DS5 | Killer cell immunoglobulin-like receptor 2DS5 | 0.815 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.846 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.714 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.721 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.838 | P07550 | ADRB2 | Beta-2 adrenergic receptor | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.72 |
| Pimozide | hsa04657 | IL-17 signaling pathway | 5.40E-07 | 9 | O00463, Q16539, P49841, P09341, P19875, P14780, P80188, P01375, P01584 | TRAF5, MAPK14, GSK3B, CXCL1, CXCL2, MMP9, LCN2, TNF, IL1B | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.932 | P14780 | MMP9 | Matrix metalloproteinase-9 | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.917 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.837 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.875 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.883 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.778 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 1 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.833 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.812 | P14780 | MMP9 | Matrix metalloproteinase-9 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.75 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.78 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.781 | P08183 | ABCB1 | ATP-dependent translocase ABCB1 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | -0.725 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P09341 | CXCL1 | Growth-regulated alpha protein | 0.788 | P14780 | MMP9 | Matrix metalloproteinase-9 | P09341 | CXCL1 | Growth-regulated alpha protein | 0.771 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P09341 | CXCL1 | Growth-regulated alpha protein | 0.7 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P09341 | CXCL1 | Growth-regulated alpha protein | 0.781 | P07550 | ADRB2 | Beta-2 adrenergic receptor | P19875 | CXCL2 | C-X-C motif chemokine 2 | -0.83 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P14780 | MMP9 | Matrix metalloproteinase-9 | 0.94 | P14780 | MMP9 | Matrix metalloproteinase-9 | P14780 | MMP9 | Matrix metalloproteinase-9 | 1 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P14780 | MMP9 | Matrix metalloproteinase-9 | 0.778 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P14780 | MMP9 | Matrix metalloproteinase-9 | 0.942 | P07550 | ADRB2 | Beta-2 adrenergic receptor | P14780 | MMP9 | Matrix metalloproteinase-9 | -0.721 | P08183 | ABCB1 | ATP-dependent translocase ABCB1 | P14780 | MMP9 | Matrix metalloproteinase-9 | -0.775 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P80188 | LCN2 | Neutrophil gelatinase-associated lipocalin | 0.715 | P14780 | MMP9 | Matrix metalloproteinase-9 | P80188 | LCN2 | Neutrophil gelatinase-associated lipocalin | 0.888 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P80188 | LCN2 | Neutrophil gelatinase-associated lipocalin | 0.721 | P07550 | ADRB2 | Beta-2 adrenergic receptor | P80188 | LCN2 | Neutrophil gelatinase-associated lipocalin | -0.757 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P01375 | TNF | Tumor necrosis factor | 0.78 | P14780 | MMP9 | Matrix metalloproteinase-9 | P01375 | TNF | Tumor necrosis factor | 0.897 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P01375 | TNF | Tumor necrosis factor | 0.774 | P07550 | ADRB2 | Beta-2 adrenergic receptor | P01375 | TNF | Tumor necrosis factor | -0.755 | P08183 | ABCB1 | ATP-dependent translocase ABCB1 | P01375 | TNF | Tumor necrosis factor | -0.769 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P01584 | IL1B | Interleukin-1 beta | 0.807 |
| Pimozide | hsa04658 | Th1 and Th2 cell differentiation | 3.60E-09 | 14 | Q04759, P07766, P20963, P09693, Q16539, P19174, P06239, Q14765, P23771, Q9UL17, P14784, P13765, P23458, Q13761 | PRKCQ, CD3E, CD247, CD3G, MAPK14, PLCG1, LCK, STAT4, GATA3, TBX21, IL2RB, HLA-DOB, JAK1, RUNX3 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q04759 | PRKCQ | Protein kinase C theta type | -0.767 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q04759 | PRKCQ | Protein kinase C theta type | -0.787 | Q13547 | HDAC1 | Histone deacetylase 1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.723 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q04759 | PRKCQ | Protein kinase C theta type | -0.762 | P07948 | LYN | Tyrosine-protein kinase Lyn | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.824 | Q13547 | HDAC1 | Histone deacetylase 1 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.802 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.786 | P14780 | MMP9 | Matrix metalloproteinase-9 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.745 | Q13547 | HDAC1 | Histone deacetylase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.87 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.77 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.835 | P14780 | MMP9 | Matrix metalloproteinase-9 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.719 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.815 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.883 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.778 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.833 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P06239 | LCK | Tyrosine-protein kinase Lck | -0.726 | P07948 | LYN | Tyrosine-protein kinase Lyn | P06239 | LCK | Tyrosine-protein kinase Lck | -0.701 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | -0.777 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | -0.861 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | -0.768 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.763 | P14780 | MMP9 | Matrix metalloproteinase-9 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.747 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.767 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.872 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.808 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.719 | Q13547 | HDAC1 | Histone deacetylase 1 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.817 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.861 | P07948 | LYN | Tyrosine-protein kinase Lyn | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.771 | Q13547 | HDAC1 | Histone deacetylase 1 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.816 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.785 | P14780 | MMP9 | Matrix metalloproteinase-9 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.714 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.73 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.757 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q13761 | RUNX3 | Runt-related transcription factor 3 | -0.855 | Q13547 | HDAC1 | Histone deacetylase 1 | Q13761 | RUNX3 | Runt-related transcription factor 3 | 0.884 |
| Pimozide | hsa04659 | Th17 cell differentiation | 1.81E-08 | 17 | Q04759, Q16539, P19174, P06239, P14784, P13765, P14778, Q9UL17, P23771, P84022, Q13485, P01584, P08238, P07766, P09693, P20963, P23458 | PRKCQ, MAPK14, PLCG1, LCK, IL2RB, HLA-DOB, IL1R1, TBX21, GATA3, SMAD3, SMAD4, IL1B, HSP90AB1, CD3E, CD3G, CD247, JAK1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q04759 | PRKCQ | Protein kinase C theta type | -0.767 | Q13547 | HDAC1 | Histone deacetylase 1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.723 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q04759 | PRKCQ | Protein kinase C theta type | -0.762 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.883 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.833 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.766 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P06239 | LCK | Tyrosine-protein kinase Lck | -0.726 | P07948 | LYN | Tyrosine-protein kinase Lyn | P06239 | LCK | Tyrosine-protein kinase Lck | -0.701 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | P07948 | LYN | Tyrosine-protein kinase Lyn | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.771 | Q13547 | HDAC1 | Histone deacetylase 1 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.816 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.835 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.785 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.73 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.766 | P07948 | LYN | Tyrosine-protein kinase Lyn | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.714 | Q13547 | HDAC1 | Histone deacetylase 1 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.854 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.762 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.764 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.872 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.719 | Q13547 | HDAC1 | Histone deacetylase 1 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.817 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.861 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.763 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.767 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | 0.725 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.729 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.746 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P01584 | IL1B | Interleukin-1 beta | 0.807 | P07948 | LYN | Tyrosine-protein kinase Lyn | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.782 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.823 | P07948 | LYN | Tyrosine-protein kinase Lyn | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.824 | Q13547 | HDAC1 | Histone deacetylase 1 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.802 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.838 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.835 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.815 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.786 | Q13547 | HDAC1 | Histone deacetylase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.87 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.77 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.757 |
| Pimozide | hsa04660 | T cell receptor signaling pathway | 4.46E-11 | 16 | P01375, Q9UDY8, Q04759, P42338, O95267, Q08881, P19174, P07766, P20963, P09693, P01732, Q13191, P06239, P04049, Q16539, P49841 | TNF, MALT1, PRKCQ, PIK3CB, RASGRP1, ITK, PLCG1, CD3E, CD247, CD3G, CD8A, CBLB, LCK, RAF1, MAPK14, GSK3B | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P01375 | TNF | Tumor necrosis factor | 0.78 | P14780 | MMP9 | Matrix metalloproteinase-9 | P01375 | TNF | Tumor necrosis factor | 0.897 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | P01375 | TNF | Tumor necrosis factor | 0.718 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P01375 | TNF | Tumor necrosis factor | 0.774 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | -0.767 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q04759 | PRKCQ | Protein kinase C theta type | -0.767 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q04759 | PRKCQ | Protein kinase C theta type | -0.787 | Q13547 | HDAC1 | Histone deacetylase 1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.723 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q04759 | PRKCQ | Protein kinase C theta type | -0.762 | Q13547 | HDAC1 | Histone deacetylase 1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.774 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.852 | P14780 | MMP9 | Matrix metalloproteinase-9 | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.792 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.716 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.806 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | -0.866 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | -0.855 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | -0.746 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | -0.736 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | -0.812 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | Q13547 | HDAC1 | Histone deacetylase 1 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.802 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.786 | P14780 | MMP9 | Matrix metalloproteinase-9 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.745 | Q13547 | HDAC1 | Histone deacetylase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.87 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.722 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.771 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.77 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.835 | P14780 | MMP9 | Matrix metalloproteinase-9 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.719 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.77 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.815 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.781 | P14780 | MMP9 | Matrix metalloproteinase-9 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.742 | Q13547 | HDAC1 | Histone deacetylase 1 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.816 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.722 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.816 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | -0.803 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | -0.793 | Q13547 | HDAC1 | Histone deacetylase 1 | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | 0.806 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | -0.719 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | -0.734 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | -0.816 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P06239 | LCK | Tyrosine-protein kinase Lck | -0.726 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.779 | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.883 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.778 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.889 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.795 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.833 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.812 | P14780 | MMP9 | Matrix metalloproteinase-9 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.75 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.861 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.823 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.781 |
| Pimozide | hsa04662 | B cell receptor signaling pathway | 2.60E-07 | 8 | P25963, P42338, P20023, P60033, P07948, P21854, Q8N149, P04049 | NFKBIA, PIK3CB, CR2, CD81, LYN, CD72, LILRA2, RAF1 | More | | Pimozide | hsa04664 | Fc epsilon RI signaling pathway | 3.61E-04 | 5 | P42338, P07948, P19174, P04049, P09917 | PIK3CB, LYN, PLCG1, RAF1, ALOX5 | More | | Pimozide | hsa04666 | Fc gamma R-mediated phagocytosis | 1.08E-04 | 10 | P08575, P19174, P04049, P23528, P49006, P06396, O14494, Q9UQC2, P14598, P17252 | PTPRC, PLCG1, RAF1, CFL1, MARCKSL1, GSN, PLPP1, GAB2, NCF1, PRKCA | More | | Pimozide | hsa04668 | TNF signaling pathway | 3.53E-04 | 8 | P01375, Q99941, P18848, P19875, P01584, P14780, P20333, O95429 | TNF, CREBL1, ATF4, CXCL2, IL1B, MMP9, TNFRSF1B, BAG4 | More | | Pimozide | hsa04670 | Leukocyte transendothelial migration | 4.07E-02 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Pimozide | hsa04672 | Intestinal immune network for IgA production | 1.24E-04 | 3 | P29965, P10747, P13765 | CD40LG, CD28, HLA-DOB | More | | Pimozide | hsa04713 | Circadian entrainment | 4.66E-06 | 8 | O15399, P0DP23, Q13557, P17252, P62873, Q14643, Q08828, P51828 | GRIN2D, CALM1, CAMK2D, PRKCA, GNB1, ITPR1, ADCY1, ADCY7 | More | | Pimozide | hsa04714 | Thermogenesis | 1.62E-06 | 9 | Q16539, P15336, P60709, P63261, P33121, Q9Y478, Q16718, O14521, P36542 | MAPK14, ATF2, ACTB, ACTG1, ACSL1, PRKAB1, NDUFA5, SDHD, ATP5C1 | More | | Pimozide | hsa04720 | Long-term potentiation | 2.39E-05 | 11 | P17252, Q13557, P16298, P0DP23, P51812, P18848, O15399, Q08828, Q02750, P04049, Q14643 | PRKCA, CAMK2D, PPP3CB, CALM1, RPS6KA3, ATF4, GRIN2D, ADCY1, MAP2K1, RAF1, ITPR1 | More | | Pimozide | hsa04722 | Neurotrophin signaling pathway | 7.10E-03 | 4 | P04049, P49841, O43524, P48023 | RAF1, GSK3B, FOXO3, FASLG | More | | Pimozide | hsa04723 | Retrograde endocannabinoid signaling | 1.88E-02 | 4 | Q14643, P17252, P62873, Q16718 | ITPR1, PRKCA, GNB1, NDUFA5 | More | | Pimozide | hsa04724 | Glutamatergic synapse | 3.32E-07 | 9 | P48058, O15399, Q08828, P51828, P17252, P62873, P63218, P50151, P15104 | GRIA4, GRIN2D, ADCY1, ADCY7, PRKCA, GNB1, GNG5, GNG10, GLUL | More | | Pimozide | hsa04725 | Cholinergic synapse | 3.72E-07 | 13 | Q08828, P51828, P22694, Q14643, P17252, P62873, P63218, P50151, P18848, Q13557, P42338, P31751, P10415 | ADCY1, ADCY7, PRKACB, ITPR1, PRKCA, GNB1, GNG5, GNG10, ATF4, CAMK2D, PIK3CB, AKT2, BCL2 | More | | Pimozide | hsa04726 | Serotonergic synapse | 1.33E-02 | 1 | P04049 | RAF1 | More | | Pimozide | hsa04727 | GABAergic synapse | 2.06E-05 | 8 | Q08828, P51828, P62873, P63218, P50151, P15104, P46459, P17252 | ADCY1, ADCY7, GNB1, GNG5, GNG10, GLUL, NSF, PRKCA | More | | Pimozide | hsa04728 | Dopaminergic synapse | 2.76E-03 | 11 | Q14643, P17252, P14416, P62873, P63218, P50151, P49841, Q16539, P49407, Q13362, P0DP23 | ITPR1, PRKCA, DRD2, GNB1, GNG5, GNG10, GSK3B, MAPK14, ARRB1, PPP2R5C, CALM1 | More | | Pimozide | hsa04730 | Long-term depression | 2.64E-03 | 4 | Q14344, P08069, P04049, P07948 | GNA13, IGF1R, RAF1, LYN | More | | Pimozide | hsa04740 | Olfactory transduction | 5.88E-03 | 4 | P62873, Q9H255, Q13557, P0DP23 | GNB1, OR51E2, CAMK2D, CALM1 | More | | Pimozide | hsa04742 | Taste transduction | 1.01E-02 | 1 | P30939 | HTR1F | More | | Pimozide | hsa04744 | Phototransduction | 6.98E-09 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Pimozide | hsa04750 | Inflammatory mediator regulation of TRP channels | 8.91E-09 | 16 | P14778, P01584, Q08828, P51828, P22694, Q13557, Q16539, P19174, P42338, Q14643, P17252, P24723, Q04759, P0DP23, P0DP24, P01042 | IL1R1, IL1B, ADCY1, ADCY7, PRKACB, CAMK2D, MAPK14, PLCG1, PIK3CB, ITPR1, PRKCA, PRKCH, PRKCQ, CALM1, CALM2, KNG1 | More | | Pimozide | hsa04810 | Regulation of actin cytoskeleton | 3.81E-02 | 1 | P04049 | RAF1 | More | | Pimozide | hsa04910 | Insulin signaling pathway | 2.51E-03 | 4 | P22694, P06737, P04049, P49841 | PRKACB, PYGL, RAF1, GSK3B | More | | Pimozide | hsa04911 | Insulin secretion | 1.82E-03 | 6 | Q08828, P51828, P17252, Q99941, P18848, Q13557 | ADCY1, ADCY7, PRKCA, CREBL1, ATF4, CAMK2D | More | | Pimozide | hsa04912 | GnRH signaling pathway | 6.57E-05 | 12 | P17252, Q08828, P51828, P18848, Q13557, Q16539, Q9Y6R4, Q14643, P0DP23, P0DP24, P22694, P04049 | PRKCA, ADCY1, ADCY7, ATF4, CAMK2D, MAPK14, MAP3K4, ITPR1, CALM1, CALM2, PRKACB, RAF1 | More | | Pimozide | hsa04913 | Ovarian steroidogenesis | 5.64E-05 | 4 | P42330, P22694, P06213, P08069 | AKR1C3, PRKACB, INSR, IGF1R | More | | Pimozide | hsa04914 | Progesterone-mediated oocyte maturation | 3.79E-04 | 12 | P08069, Q17RY0, Q08828, P51828, P31751, Q13370, Q9UJX4, Q9Y6D9, P08238, P51812, Q02750, P04049 | IGF1R, CPEB4, ADCY1, ADCY7, AKT2, PDE3B, ANAPC5, MAD1L1, HSP90AB1, RPS6KA3, MAP2K1, RAF1 | More | | Pimozide | hsa04915 | Estrogen signaling pathway | 3.98E-04 | 12 | P04049, Q99941, P18848, Q08828, P51828, P31751, P07900, P08238, P11142, P0DP23, Q15788, P10415 | RAF1, CREBL1, ATF4, ADCY1, ADCY7, AKT2, HSP90AA1, HSP90AB1, HSPA8, CALM1, NCOA1, BCL2 | More | | Pimozide | hsa04916 | Melanogenesis | 1.79E-02 | 5 | P0DP23, Q9UJU2, P17252, P04628, P04049 | CALM1, LEF1, PRKCA, WNT1, RAF1 | More | | Pimozide | hsa04917 | Prolactin signaling pathway | 6.63E-03 | 1 | P04049 | RAF1 | More | | Pimozide | hsa04919 | Thyroid hormone signaling pathway | 6.15E-05 | 7 | P49841, P04049, P22694, P60709, P63261, O60244, Q9NVC6 | GSK3B, RAF1, PRKACB, ACTB, ACTG1, MED14, MED17 | More | | Pimozide | hsa04920 | Adipocytokine signaling pathway | 5.67E-03 | 6 | Q06124, P33121, Q9Y478, Q04759, Q9Y4H2, P01375 | PTPN11, ACSL1, PRKAB1, PRKCQ, IRS2, TNF | More | | Pimozide | hsa04921 | Oxytocin signaling pathway | 1.43E-04 | 4 | P04049, P60660, P60709, P63261 | RAF1, MYL6, ACTB, ACTG1 | More | | Pimozide | hsa04922 | Glucagon signaling pathway | 3.47E-02 | 4 | Q12778, Q13370, P0DP23, Q14643 | FOXO1, PDE3B, CALM1, ITPR1 | More | | Pimozide | hsa04923 | Regulation of lipolysis in adipocytes | 2.75E-04 | 8 | Q08828, P51828, P07550, P06213, Q13370, P42338, Q9Y4H2, P31751 | ADCY1, ADCY7, ADRB2, INSR, PDE3B, PIK3CB, IRS2, AKT2 | More | | Pimozide | hsa04924 | Renin secretion | 6.00E-06 | 5 | P22694, P07550, Q14643, Q13370, P0DP23 | PRKACB, ADRB2, ITPR1, PDE3B, CALM1 | More | | Pimozide | hsa04925 | Aldosterone synthesis and secretion | 1.87E-05 | 8 | Q99941, P18848, Q08828, P51828, P0DP23, P17252, Q13557, P23634 | CREBL1, ATF4, ADCY1, ADCY7, CALM1, PRKCA, CAMK2D, ATP2B4 | More | | Pimozide | hsa04926 | Relaxin signaling pathway | 1.17E-04 | 10 | P42338, P63218, P50151, P18848, P22694, P49767, P14780, P04049, P30679, P49407 | PIK3CB, GNG5, GNG10, ATF4, PRKACB, VEGFC, MMP9, RAF1, GNA15, ARRB1 | More | | Pimozide | hsa04927 | Cortisol synthesis and secretion | 1.27E-03 | 3 | Q14643, P18848, P22694 | ITPR1, ATF4, PRKACB | More | | Pimozide | hsa04928 | Parathyroid hormone synthesis, secretion and action | 2.75E-03 | 5 | Q14643, P22694, P23771, P04049, P10415 | ITPR1, PRKACB, GATA3, RAF1, BCL2 | More | | Pimozide | hsa04929 | GnRH secretion | 3.50E-03 | 3 | P42338, P49407, P04049 | PIK3CB, ARRB1, RAF1 | More | | Pimozide | hsa04930 | Type II diabetes mellitus | 3.14E-02 | 1 | P06213 | INSR | More | | Pimozide | hsa04931 | Insulin resistance | 1.94E-02 | 3 | P01375, P49841, P06737 | TNF, GSK3B, PYGL | More | | Pimozide | hsa04932 | Non-alcoholic fatty liver disease | 1.52E-05 | 10 | P01375, P49841, O43521, P18848, P48023, O75460, P01584, P13073, Q16718, O14521 | TNF, GSK3B, BCL2L11, ATF4, FASLG, ERN1, IL1B, COX4I1, NDUFA5, SDHD | More | | Pimozide | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 1.05E-08 | 11 | P84022, Q13485, P01584, P42224, P10415, P31751, P42338, Q12778, P49767, P17252, P19174 | SMAD3, SMAD4, IL1B, STAT1, BCL2, AKT2, PIK3CB, FOXO1, VEGFC, PRKCA, PLCG1 | More | | Pimozide | hsa04934 | Cushing syndrome | 5.32E-04 | 7 | Q14643, Q99941, P51828, P22694, O15169, Q13557, P04628 | ITPR1, CREBL1, ADCY7, PRKACB, AXIN1, CAMK2D, WNT1 | More | | Pimozide | hsa04935 | Growth hormone synthesis, secretion and action | 1.77E-02 | 7 | P19174, Q08828, P51828, P04049, P17252, P31751, P42224 | PLCG1, ADCY1, ADCY7, RAF1, PRKCA, AKT2, STAT1 | More | | Pimozide | hsa04940 | Type I diabetes mellitus | 1.87E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Pimozide | hsa04960 | Aldosterone-regulated sodium reabsorption | 3.14E-02 | 1 | P06213 | INSR | More | | Pimozide | hsa04964 | Proximal tubule bicarbonate reclamation | 4.93E-02 | 1 | P00918 | CA2 | More | | Pimozide | hsa04966 | Collecting duct acid secretion | 2.07E-03 | 3 | Q13488, P00918, Q9Y666 | TCIRG1, CA2, SLC12A7 | More | | Pimozide | hsa04970 | Salivary secretion | 6.63E-06 | 9 | P07550, Q08828, P51828, P22694, Q14643, P23634, P17252, P0DP23, P49913 | ADRB2, ADCY1, ADCY7, PRKACB, ITPR1, ATP2B4, PRKCA, CALM1, CAMP | More | | Pimozide | hsa04971 | Gastric acid secretion | 6.13E-04 | 5 | P51828, P15311, P60709, P63261, Q13557 | ADCY7, VIL2, ACTB, ACTG1, CAMK2D | More | | Pimozide | hsa04972 | Pancreatic secretion | 1.41E-04 | 7 | Q14643, P20020, P23634, P17252, Q08828, P51828, P62491 | ITPR1, ATP2B1, ATP2B4, PRKCA, ADCY1, ADCY7, RAB11A | More | | Pimozide | hsa04973 | Carbohydrate digestion and absorption | 4.61E-03 | 3 | P13866, O43451, P42338 | SLC5A1, MGAM, PIK3CB | More | | Pimozide | hsa04975 | Fat digestion and absorption | 2.80E-02 | 1 | O14494 | PLPP1 | More | | Pimozide | hsa04976 | Bile secretion | 3.62E-04 | 4 | O43315, P22694, P08183, P13866 | AQP9, PRKACB, ABCB1, SLC5A1 | More | | Pimozide | hsa05010 | Alzheimer disease | 3.09E-05 | 26 | Q92542, Q16718, O14521, P05496, P13073, P12074, Q14643, O15399, Q9NZJ5, O75460, P0DP23, P0DP24, Q13564, P01584, P18848, Q71U36, Q13509, P68371, O15169, P09603, P05141, P21796, P45880, Q08752, P17861, P62195 | NCSTN, NDUFA5, SDHD, ATP5G1, COX4I1, COX6A1, ITPR1, GRIN2D, EIF2AK3, ERN1, CALM1, CALM2, APPBP1, IL1B, ATF4, TUBA1A, TUBB3, TUBB2C, AXIN1, CSF1, SLC25A5, VDAC1, VDAC2, PPID, XBP1, PSMC5 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | Q92542 | NCSTN | Nicastrin | 0.706 | P17252 | PRKCA | Protein kinase C alpha type | Q16718 | NDUFA5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | 0.811 | P17252 | PRKCA | Protein kinase C alpha type | O14521 | SDHD | Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial | 0.822 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P05496 | ATP5G1 | ATP synthase F(0) complex subunit C1, mitochondrial | 0.733 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.717 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P12074 | COX6A1 | Cytochrome c oxidase subunit 6A1, mitochondrial | 0.754 | P17252 | PRKCA | Protein kinase C alpha type | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | 0.786 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | O15399 | GRIN2D | Glutamate receptor ionotropic, NMDA 2D | -0.707 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | Q9NZJ5 | EIF2AK3 | Eukaryotic translation initiation factor 2-alpha kinase 3 | 0.728 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | 0.731 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | 0.702 | P17252 | PRKCA | Protein kinase C alpha type | P0DP23 | CALM1 | Calmodulin-1 | -0.776 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P0DP24 | CALM2 | Calmodulin-2 | 0.759 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | Q13564 | APPBP1 | NEDD8-activating enzyme E1 regulatory subunit | 0.873 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P01584 | IL1B | Interleukin-1 beta | 0.75 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P01584 | IL1B | Interleukin-1 beta | 0.825 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.723 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | Q71U36 | TUBA1A | Tubulin alpha-1A chain | -0.85 | P17252 | PRKCA | Protein kinase C alpha type | Q13509 | TUBB3 | Tubulin beta-3 chain | -0.756 | P17252 | PRKCA | Protein kinase C alpha type | P68371 | TUBB2C | Tubulin beta-4B chain | -0.842 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | O15169 | AXIN1 | Axin-1 | 0.742 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | P09603 | CSF1 | Macrophage colony-stimulating factor 1 | -0.789 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.797 | P61088 | UBE2N | Ubiquitin-conjugating enzyme E2 N | P21796 | VDAC1 | Voltage-dependent anion-selective channel protein 1 | 0.88 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P45880 | VDAC2 | Voltage-dependent anion-selective channel protein 2 | 0.708 | P17252 | PRKCA | Protein kinase C alpha type | Q08752 | PPID | Peptidyl-prolyl cis-trans isomerase D | 0.725 | P17861 | XBP1 | X-box-binding protein 1 | P17861 | XBP1 | X-box-binding protein 1 | 1 | P17861 | XBP1 | X-box-binding protein 1 | P62195 | PSMC5 | 26S proteasome regulatory subunit 8 | 0.816 |
| Pimozide | hsa05012 | Parkinson disease | 1.46E-03 | 13 | Q16718, O14521, P13073, P05141, O75460, P18848, P17861, P62195, Q14643, P0DP23, P0DP24, Q13509, P68371 | NDUFA5, SDHD, COX4I1, SLC25A5, ERN1, ATF4, XBP1, PSMC5, ITPR1, CALM1, CALM2, TUBB3, TUBB2C | More | | Pimozide | hsa05014 | Amyotrophic lateral sclerosis | 1.52E-04 | 6 | P36542, P17861, P62195, Q53GS7, P60709, P63261 | ATP5C1, XBP1, PSMC5, GLE1, ACTB, ACTG1 | More | | Pimozide | hsa05016 | Huntington disease | 4.87E-02 | 5 | P13073, P24928, P62487, P05141, O75460 | COX4I1, POLR2A, POLR2G, SLC25A5, ERN1 | More | | Pimozide | hsa05017 | Spinocerebellar ataxia | 7.02E-05 | 13 | P17252, Q92915, O75460, Q8TB72, O15399, P42338, P31751, P17861, P28070, P43686, P62195, O00232, P21796 | PRKCA, FGF14, ERN1, PUM2, GRIN2D, PIK3CB, AKT2, XBP1, PSMB4, PSMC4, PSMC5, PSMD12, VDAC1 | More | | Pimozide | hsa05020 | Prion disease | 9.54E-06 | 18 | P01584, P46531, P11142, Q16718, O14521, P05496, P12074, Q92736, Q14643, P45880, O60282, Q13509, P68371, P49841, Q99941, P14598, Q15080, Q16539 | IL1B, NOTCH1, HSPA8, NDUFA5, SDHD, ATP5G1, COX6A1, RYR2, ITPR1, VDAC2, KIF5C, TUBB3, TUBB2C, GSK3B, CREBL1, NCF1, NCF4, MAPK14 | More | | Pimozide | hsa05022 | Pathways of neurodegeneration - multiple diseases | 4.04E-06 | 23 | Q14643, Q13509, P68371, P49841, P10415, Q16718, O14521, P13073, Q06055, O75460, P18848, P17861, Q13561, P05141, P17252, P20333, Q16539, P01584, Q08752, O15020, P0DP23, P0DP24, P62195 | ITPR1, TUBB3, TUBB2C, GSK3B, BCL2, NDUFA5, SDHD, COX4I1, ATP5G2, ERN1, ATF4, XBP1, DCTN2, SLC25A5, PRKCA, TNFRSF1B, MAPK14, IL1B, PPID, SPTBN2, CALM1, CALM2, PSMC5 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P17252 | PRKCA | Protein kinase C alpha type | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | 0.786 | P17252 | PRKCA | Protein kinase C alpha type | Q13509 | TUBB3 | Tubulin beta-3 chain | -0.756 | P17252 | PRKCA | Protein kinase C alpha type | P68371 | TUBB2C | Tubulin beta-4B chain | -0.842 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | P49841 | GSK3B | Glycogen synthase kinase-3 beta | -0.714 | P17252 | PRKCA | Protein kinase C alpha type | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.844 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q16718 | NDUFA5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | 0.757 | P17252 | PRKCA | Protein kinase C alpha type | Q16718 | NDUFA5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | 0.811 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | O14521 | SDHD | Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial | 0.732 | P17252 | PRKCA | Protein kinase C alpha type | O14521 | SDHD | Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial | 0.822 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.717 | P30530 | AXL | Tyrosine-protein kinase receptor UFO | Q06055 | ATP5G2 | ATP synthase F(0) complex subunit C2, mitochondrial | -0.735 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | 0.702 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.723 | P17861 | XBP1 | X-box-binding protein 1 | P17861 | XBP1 | X-box-binding protein 1 | 1 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q13561 | DCTN2 | Dynactin subunit 2 | -0.771 | P17252 | PRKCA | Protein kinase C alpha type | Q13561 | DCTN2 | Dynactin subunit 2 | -0.844 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.797 | P17252 | PRKCA | Protein kinase C alpha type | P17252 | PRKCA | Protein kinase C alpha type | 1 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P20333 | TNFRSF1B | Tumor necrosis factor receptor superfamily member 1B | 0.706 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | -0.744 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P01584 | IL1B | Interleukin-1 beta | 0.825 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q08752 | PPID | Peptidyl-prolyl cis-trans isomerase D | 0.859 | P17252 | PRKCA | Protein kinase C alpha type | Q08752 | PPID | Peptidyl-prolyl cis-trans isomerase D | 0.725 | P30530 | AXL | Tyrosine-protein kinase receptor UFO | O15020 | SPTBN2 | Spectrin beta chain, non-erythrocytic 2 | 0.738 | P17252 | PRKCA | Protein kinase C alpha type | P0DP23 | CALM1 | Calmodulin-1 | -0.776 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P0DP24 | CALM2 | Calmodulin-2 | 0.759 | P17861 | XBP1 | X-box-binding protein 1 | P62195 | PSMC5 | 26S proteasome regulatory subunit 8 | 0.816 |
| Pimozide | hsa05031 | Amphetamine addiction | 3.62E-03 | 7 | O15399, P0DP23, Q13557, P22694, P18848, P17252, Q13547 | GRIN2D, CALM1, CAMK2D, PRKACB, ATF4, PRKCA, HDAC1 | More | | Pimozide | hsa05032 | Morphine addiction | 1.94E-03 | 9 | Q08828, P51828, P62873, P63218, P50151, Q13370, Q07343, P17252, P43250 | ADCY1, ADCY7, GNB1, GNG5, GNG10, PDE3B, PDE4B, PRKCA, GRK6 | More | | Pimozide | hsa05034 | Alcoholism | 4.61E-05 | 5 | P04049, Q93077, P62807, O60814, P68431 | RAF1, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Pimozide | hsa05100 | Bacterial invasion of epithelial cells | 1.72E-03 | 5 | Q14141, P60709, P63261, Q05397, Q96JJ3 | SEPT6, ACTB, ACTG1, PTK2, ELMO2 | More | | Pimozide | hsa05110 | Vibrio cholerae infection | 2.30E-05 | 6 | Q13488, Q99437, P17252, P19174, P60709, P63261 | TCIRG1, ATP6V0B, PRKCA, PLCG1, ACTB, ACTG1 | More | | Pimozide | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 1.84E-05 | 7 | Q16539, P09341, P19875, P19174, P25024, P25025, P07948 | MAPK14, CXCL1, CXCL2, PLCG1, CXCR1, CXCR2, LYN | More | | Pimozide | hsa05130 | Pathogenic Escherichia coli infection | 9.80E-03 | 4 | Q92974, P63261, Q06124, O95487 | ARHGEF2, ACTG1, PTPN11, SEC24B | More | | Pimozide | hsa05131 | Shigellosis | 3.00E-04 | 16 | P68431, Q9UDY8, Q9NQL2, P0CG47, Q14141, Q14247, Q96JJ3, P60709, P63261, Q05397, Q14643, Q12778, P07384, Q13315, P10415, Q08752 | H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, MALT1, RRAGD, UBB, SEPT6, CTTN, ELMO2, ACTB, ACTG1, PTK2, ITPR1, FOXO1, CAPN1, ATM, BCL2, PPID | More | | Pimozide | hsa05132 | Salmonella infection | 4.36E-09 | 21 | P51617, P01584, P08238, P04049, Q9UJU2, P63261, Q96RF0, O00471, Q13546, Q13489, P10415, P08575, O75369, O60603, Q9BQS8, Q13561, O60282, Q13509, P68371, P49754, Q9NP90 | IRAK1, IL1B, HSP90AB1, RAF1, LEF1, ACTG1, SNAG1, EXOC5, RIPK1, BIRC3, BCL2, PTPRC, FLNB, TLR2, FYCO1, DCTN2, KIF5C, TUBB3, TUBB2C, VPS41, RAB9B | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P10415 | BCL2 | Apoptosis regulator Bcl-2 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | 0.807 | P0DP25 | CALM3 | Calmodulin-3 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | -0.703 | P0DP24 | CALM2 | Calmodulin-2 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | -0.703 | P0DP24 | CALM2 | Calmodulin-2 | P01584 | IL1B | Interleukin-1 beta | 0.72 | P0DP25 | CALM3 | Calmodulin-3 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.775 | P0DP24 | CALM2 | Calmodulin-2 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.775 | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 | P17252 | PRKCA | Protein kinase C alpha type | Q9UJU2 | LEF1 | Lymphoid enhancer-binding factor 1 | 0.881 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | Q9UJU2 | LEF1 | Lymphoid enhancer-binding factor 1 | 0.787 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q9UJU2 | LEF1 | Lymphoid enhancer-binding factor 1 | 0.908 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P63261 | ACTG1 | Actin, cytoplasmic 2 | 0.719 | P0DP24 | CALM2 | Calmodulin-2 | Q96RF0 | SNAG1 | Sorting nexin-18 | 0.703 | Q9UGN5 | PARP2 | Poly [ADP-ribose] polymerase 2 | O00471 | EXOC5 | Exocyst complex component 5 | 0.74 | P08235 | NR3C2 | Mineralocorticoid receptor | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | -0.749 | P17252 | PRKCA | Protein kinase C alpha type | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.849 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.71 | P08235 | NR3C2 | Mineralocorticoid receptor | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.868 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.848 | P0DP25 | CALM3 | Calmodulin-3 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.8 | P0DP24 | CALM2 | Calmodulin-2 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.8 | P17252 | PRKCA | Protein kinase C alpha type | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.844 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.859 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 1 | P0DP25 | CALM3 | Calmodulin-3 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.772 | P0DP24 | CALM2 | Calmodulin-2 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.772 | P0DP24 | CALM2 | Calmodulin-2 | P08575 | PTPRC | Receptor-type tyrosine-protein phosphatase C | 0.716 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | O75369 | FLNB | Filamin-B | -0.762 | P0DP25 | CALM3 | Calmodulin-3 | O75369 | FLNB | Filamin-B | 0.874 | P0DP24 | CALM2 | Calmodulin-2 | O75369 | FLNB | Filamin-B | 0.874 | P17252 | PRKCA | Protein kinase C alpha type | O60603 | TLR2 | Toll-like receptor 2 | -0.716 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | O60603 | TLR2 | Toll-like receptor 2 | -0.797 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | O60603 | TLR2 | Toll-like receptor 2 | -0.884 | P17252 | PRKCA | Protein kinase C alpha type | Q9BQS8 | FYCO1 | FYVE and coiled-coil domain-containing protein 1 | 0.701 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | Q9BQS8 | FYCO1 | FYVE and coiled-coil domain-containing protein 1 | 0.737 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q9BQS8 | FYCO1 | FYVE and coiled-coil domain-containing protein 1 | 0.929 | P17252 | PRKCA | Protein kinase C alpha type | Q13561 | DCTN2 | Dynactin subunit 2 | -0.844 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | Q13561 | DCTN2 | Dynactin subunit 2 | -0.862 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q13561 | DCTN2 | Dynactin subunit 2 | -0.843 | P0DP25 | CALM3 | Calmodulin-3 | Q13561 | DCTN2 | Dynactin subunit 2 | 0.739 | P0DP24 | CALM2 | Calmodulin-2 | Q13561 | DCTN2 | Dynactin subunit 2 | 0.739 | Q9UGN5 | PARP2 | Poly [ADP-ribose] polymerase 2 | O60282 | KIF5C | Kinesin heavy chain isoform 5C | -0.748 | P08235 | NR3C2 | Mineralocorticoid receptor | O60282 | KIF5C | Kinesin heavy chain isoform 5C | 0.753 | P17252 | PRKCA | Protein kinase C alpha type | Q13509 | TUBB3 | Tubulin beta-3 chain | -0.756 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | Q13509 | TUBB3 | Tubulin beta-3 chain | -0.782 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q13509 | TUBB3 | Tubulin beta-3 chain | -0.809 | P0DP25 | CALM3 | Calmodulin-3 | Q13509 | TUBB3 | Tubulin beta-3 chain | 0.892 | P0DP24 | CALM2 | Calmodulin-2 | Q13509 | TUBB3 | Tubulin beta-3 chain | 0.892 | P17252 | PRKCA | Protein kinase C alpha type | P68371 | TUBB2C | Tubulin beta-4B chain | -0.842 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P68371 | TUBB2C | Tubulin beta-4B chain | -0.726 | P08235 | NR3C2 | Mineralocorticoid receptor | P68371 | TUBB2C | Tubulin beta-4B chain | -0.747 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P68371 | TUBB2C | Tubulin beta-4B chain | -0.766 | P0DP25 | CALM3 | Calmodulin-3 | P68371 | TUBB2C | Tubulin beta-4B chain | 0.742 | P0DP24 | CALM2 | Calmodulin-2 | P68371 | TUBB2C | Tubulin beta-4B chain | 0.742 | P0DP25 | CALM3 | Calmodulin-3 | P49754 | VPS41 | Vacuolar protein sorting-associated protein 41 homolog | 0.723 | P0DP24 | CALM2 | Calmodulin-2 | P49754 | VPS41 | Vacuolar protein sorting-associated protein 41 homolog | 0.723 | P0DP24 | CALM2 | Calmodulin-2 | Q9NP90 | RAB9B | Ras-related protein Rab-9B | 0.791 |
| Pimozide | hsa05133 | Pertussis | 6.00E-05 | 6 | P0DP23, P01584, P23528, P09871, P0C0L4, P51617 | CALM1, IL1B, CFL1, C1S, C4A, IRAK1 | More | | Pimozide | hsa05134 | Legionellosis | 1.29E-02 | 4 | P11215, P11142, P09341, P19875 | ITGAM, HSPA8, CXCL1, CXCL2 | More | | Pimozide | hsa05135 | Yersinia infection | 5.31E-03 | 8 | P60709, P63261, Q16513, P13612, P06239, Q16539, P01375, P49841 | ACTB, ACTG1, PKN2, ITGA4, LCK, MAPK14, TNF, GSK3B | More | | Pimozide | hsa05140 | Leishmaniasis | 1.83E-10 | 14 | P13612, O75015, P14598, P23458, P42224, P13765, O60603, P25963, P01375, P01584, P29350, P49006, Q16539, Q15080 | ITGA4, FCGR3B, NCF1, JAK1, STAT1, HLA-DOB, TLR2, NFKBIA, TNF, IL1B, PTPN6, MARCKSL1, MAPK14, NCF4 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P13612 | ITGA4 | Integrin alpha-4 | -0.797 | P14780 | MMP9 | Matrix metalloproteinase-9 | P13612 | ITGA4 | Integrin alpha-4 | -0.7 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P13612 | ITGA4 | Integrin alpha-4 | -0.771 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.92 | P14780 | MMP9 | Matrix metalloproteinase-9 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.928 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.814 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.893 | P29350 | PTPN6 | Tyrosine-protein phosphatase non-receptor type 6 | P14598 | NCF1 | Neutrophil cytosol factor 1 | 0.818 | P17252 | PRKCA | Protein kinase C alpha type | P14598 | NCF1 | Neutrophil cytosol factor 1 | -0.821 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P14598 | NCF1 | Neutrophil cytosol factor 1 | -0.708 | O15182 | CETN3 | Centrin-3 | P14598 | NCF1 | Neutrophil cytosol factor 1 | -0.848 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.757 | P29350 | PTPN6 | Tyrosine-protein phosphatase non-receptor type 6 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.81 | P17252 | PRKCA | Protein kinase C alpha type | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | -0.706 | P17252 | PRKCA | Protein kinase C alpha type | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.709 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.75 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.785 | P14780 | MMP9 | Matrix metalloproteinase-9 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.714 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.754 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.73 | P17252 | PRKCA | Protein kinase C alpha type | O60603 | TLR2 | Toll-like receptor 2 | -0.716 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | O60603 | TLR2 | Toll-like receptor 2 | -0.797 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | O60603 | TLR2 | Toll-like receptor 2 | 0.842 | P14780 | MMP9 | Matrix metalloproteinase-9 | O60603 | TLR2 | Toll-like receptor 2 | 0.89 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O60603 | TLR2 | Toll-like receptor 2 | 0.73 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | O60603 | TLR2 | Toll-like receptor 2 | 0.867 | O15182 | CETN3 | Centrin-3 | O60603 | TLR2 | Toll-like receptor 2 | -0.725 | P29350 | PTPN6 | Tyrosine-protein phosphatase non-receptor type 6 | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.841 | O15182 | CETN3 | Centrin-3 | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | -0.777 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P01375 | TNF | Tumor necrosis factor | 0.78 | P14780 | MMP9 | Matrix metalloproteinase-9 | P01375 | TNF | Tumor necrosis factor | 0.897 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P01375 | TNF | Tumor necrosis factor | 0.774 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P01584 | IL1B | Interleukin-1 beta | 0.807 | P29350 | PTPN6 | Tyrosine-protein phosphatase non-receptor type 6 | P29350 | PTPN6 | Tyrosine-protein phosphatase non-receptor type 6 | 1 | P17252 | PRKCA | Protein kinase C alpha type | P29350 | PTPN6 | Tyrosine-protein phosphatase non-receptor type 6 | -0.754 | O15182 | CETN3 | Centrin-3 | P29350 | PTPN6 | Tyrosine-protein phosphatase non-receptor type 6 | -0.76 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P49006 | MARCKSL1 | MARCKS-related protein | 0.706 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P49006 | MARCKSL1 | MARCKS-related protein | -0.852 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.883 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.778 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 1 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.833 | P29350 | PTPN6 | Tyrosine-protein phosphatase non-receptor type 6 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.752 | P17252 | PRKCA | Protein kinase C alpha type | Q15080 | NCF4 | Neutrophil cytosol factor 4 | -0.836 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | Q15080 | NCF4 | Neutrophil cytosol factor 4 | -0.89 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.762 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.869 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.764 | O15182 | CETN3 | Centrin-3 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | -0.715 |
| Pimozide | hsa05143 | African trypanosomiasis | 1.93E-04 | 7 | P01375, P01584, P69905, P68871, P48023, P17252, P01042 | TNF, IL1B, HBA2, HBB, FASLG, PRKCA, KNG1 | More | | Pimozide | hsa05144 | Malaria | 8.07E-08 | 8 | P60033, P69905, P68871, O60603, P01375, P35443, P01584, P26718 | CD81, HBA2, HBB, TLR2, TNF, THBS4, IL1B, KLRK1 | More | | Pimozide | hsa05145 | Toxoplasmosis | 2.35E-06 | 11 | P51617, P10415, Q13489, P23458, P42224, P13765, P31751, P11142, O60603, P29965, Q13651 | IRAK1, BCL2, BIRC3, JAK1, STAT1, HLA-DOB, AKT2, HSPA8, TLR2, CD40LG, IL10RA | More | | Pimozide | hsa05146 | Amoebiasis | 1.05E-08 | 14 | P01584, P09341, P19875, P14778, P27930, P01375, O60603, P42338, P11215, P05089, P30679, P22694, P12814, P08311 | IL1B, CXCL1, CXCL2, IL1R1, IL1R2, TNF, TLR2, PIK3CB, ITGAM, ARG1, GNA15, PRKACB, ACTN1, CTSG | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P01584 | IL1B | Interleukin-1 beta | 0.807 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P09341 | CXCL1 | Growth-regulated alpha protein | 0.788 | P14780 | MMP9 | Matrix metalloproteinase-9 | P09341 | CXCL1 | Growth-regulated alpha protein | 0.771 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P09341 | CXCL1 | Growth-regulated alpha protein | 0.7 | Q13547 | HDAC1 | Histone deacetylase 1 | P09341 | CXCL1 | Growth-regulated alpha protein | -0.736 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P09341 | CXCL1 | Growth-regulated alpha protein | 0.781 | Q13547 | HDAC1 | Histone deacetylase 1 | P19875 | CXCL2 | C-X-C motif chemokine 2 | -0.862 | P07550 | ADRB2 | Beta-2 adrenergic receptor | P19875 | CXCL2 | C-X-C motif chemokine 2 | -0.83 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.766 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.76 | Q13547 | HDAC1 | Histone deacetylase 1 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.854 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.762 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.926 | P14780 | MMP9 | Matrix metalloproteinase-9 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.851 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.811 | Q13547 | HDAC1 | Histone deacetylase 1 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | -0.837 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.924 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P01375 | TNF | Tumor necrosis factor | 0.78 | P14780 | MMP9 | Matrix metalloproteinase-9 | P01375 | TNF | Tumor necrosis factor | 0.897 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P01375 | TNF | Tumor necrosis factor | 0.774 | P07550 | ADRB2 | Beta-2 adrenergic receptor | P01375 | TNF | Tumor necrosis factor | -0.755 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | O60603 | TLR2 | Toll-like receptor 2 | 0.842 | P14780 | MMP9 | Matrix metalloproteinase-9 | O60603 | TLR2 | Toll-like receptor 2 | 0.89 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O60603 | TLR2 | Toll-like receptor 2 | 0.73 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | O60603 | TLR2 | Toll-like receptor 2 | 0.867 | Q13547 | HDAC1 | Histone deacetylase 1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.774 | Q13547 | HDAC1 | Histone deacetylase 1 | P11215 | ITGAM | Integrin alpha-M | -0.751 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P05089 | ARG1 | Arginase-1 | 0.848 | P14780 | MMP9 | Matrix metalloproteinase-9 | P05089 | ARG1 | Arginase-1 | 0.881 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P05089 | ARG1 | Arginase-1 | 0.702 | Q13547 | HDAC1 | Histone deacetylase 1 | P05089 | ARG1 | Arginase-1 | -0.769 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P05089 | ARG1 | Arginase-1 | 0.811 | P07550 | ADRB2 | Beta-2 adrenergic receptor | P30679 | GNA15 | Guanine nucleotide-binding protein subunit alpha-15 | -0.8 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | -0.772 | P14780 | MMP9 | Matrix metalloproteinase-9 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | -0.826 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | -0.779 | P07550 | ADRB2 | Beta-2 adrenergic receptor | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | 0.724 | Q13547 | HDAC1 | Histone deacetylase 1 | P12814 | ACTN1 | Alpha-actinin-1 | -0.887 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P08311 | CTSG | Cathepsin G | 0.744 | P14780 | MMP9 | Matrix metalloproteinase-9 | P08311 | CTSG | Cathepsin G | 0.79 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P08311 | CTSG | Cathepsin G | 0.709 |
| Pimozide | hsa05150 | Staphylococcus aureus infection | 1.91E-02 | 4 | Q14532, P59665, P59666, P49913 | KRT32, DEFA1; DEFA1B, DEFA3, CAMP | More | | Pimozide | hsa05152 | Tuberculosis | 3.00E-05 | 13 | P04049, Q13488, Q99437, P0DP23, P42224, P48382, O60603, P10415, P13765, P25774, P01568, Q9UDY8, P51617 | RAF1, TCIRG1, ATP6V0B, CALM1, STAT1, RFX5, TLR2, BCL2, HLA-DOB, CTSS, IFNA21, MALT1, IRAK1 | More | | Pimozide | hsa05160 | Hepatitis C | 1.40E-03 | 5 | P60033, P04049, P49841, P01375, P48023 | CD81, RAF1, GSK3B, TNF, FASLG | More | | Pimozide | hsa05161 | Hepatitis B | 2.85E-05 | 11 | P17252, P04049, P18848, P23458, Q13485, P31751, P10415, P27348, P01568, P42224, P51617 | PRKCA, RAF1, ATF4, JAK1, SMAD4, AKT2, BCL2, YWHAQ, IFNA21, STAT1, IRAK1 | More | | Pimozide | hsa05162 | Measles | 1.74E-04 | 10 | P51617, P01568, P23458, P42224, P14784, P31751, P11142, P01584, Q9NP90, P10415 | IRAK1, IFNA21, JAK1, STAT1, IL2RB, AKT2, HSPA8, IL1B, RAB9B, BCL2 | More | | Pimozide | hsa05163 | Human cytomegalovirus infection | 3.46E-05 | 25 | P31751, P04049, P01375, P62873, P63218, P50151, Q14643, P0DP23, Q8NHW4, Q08828, P51828, P23458, P49841, P14778, P01584, P61073, P17252, Q13651, P25025, Q16539, P18848, P04637, O00463, P61769, P01568 | AKT2, RAF1, TNF, GNB1, GNG5, GNG10, ITPR1, CALM1, CCL4L2, ADCY1, ADCY7, JAK1, GSK3B, IL1R1, IL1B, CXCR4, PRKCA, IL10RA, CXCR2, MAPK14, ATF4, TP53, TRAF5, B2M, IFNA21 | More | | Pimozide | hsa05164 | Influenza A | 8.97E-04 | 4 | P48551, P04049, P60709, P63261 | IFNAR2, RAF1, ACTB, ACTG1 | More | | Pimozide | hsa05165 | Human papillomavirus infection | 3.10E-02 | 8 | P16144, Q05086, P01568, P42224, Q13488, Q13362, Q12778, Q13315 | ITGB4, UBE3A, IFNA21, STAT1, TCIRG1, PPP2R5C, FOXO1, ATM | More | | Pimozide | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 1.48E-02 | 7 | P01568, P42224, P62873, Q14643, P04049, P0DP23, Q9UJU2 | IFNA21, STAT1, GNB1, ITPR1, RAF1, CALM1, LEF1 | More | | Pimozide | hsa05168 | Herpes simplex virus 1 infection | 4.23E-06 | 24 | P25963, P01568, P01584, Q9UBU9, P23458, P42224, Q07955, Q01130, Q13243, Q13489, P51617, P61769, P31751, Q9Y2A4, Q13398, P51522, Q6P280, P17038, Q03923, P52738, O75820, Q9UDV6, P10415, Q14232 | NFKBIA, IFNA21, IL1B, NXF1, JAK1, STAT1, SFRS1, SFRS2, SFRS5, BIRC3, IRAK1, B2M, AKT2, ZNF443, ZNF211, ZNF83, ZNF529, ZNF43, ZNF85, ZNF140, ZNF189, ZNF212, BCL2, EIF2B1 | More | | Pimozide | hsa05169 | Epstein-Barr virus infection | 3.72E-02 | 6 | Q13547, P42338, P07948, Q13761, O75293, P07766 | HDAC1, PIK3CB, LYN, RUNX3, GADD45B, CD3E | More | | Pimozide | hsa05170 | Human immunodeficiency virus 1 infection | 8.22E-10 | 22 | P31751, P04049, Q02750, P62873, P62879, P16298, P0DP23, P61073, Q05397, P17252, O00463, P61769, Q14643, P01568, P51617, O60603, Q13315, P19174, P23528, P10415, Q93034, Q9Y6Q5 | AKT2, RAF1, MAP2K1, GNB1, GNB2, PPP3CB, CALM1, CXCR4, PTK2, PRKCA, TRAF5, B2M, ITPR1, IFNA21, IRAK1, TLR2, ATM, PLCG1, CFL1, BCL2, CUL5, AP1M2 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P0DP23 | CALM1 | Calmodulin-1 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 0.761 | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 | P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | 0.93 | P0DP23 | CALM1 | Calmodulin-1 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.853 | P17252 | PRKCA | Protein kinase C alpha type | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.852 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.777 | P0DP25 | CALM3 | Calmodulin-3 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.853 | P0DP24 | CALM2 | Calmodulin-2 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.853 | P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | P62879 | GNB2 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 | 0.96 | P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | P16298 | PPP3CB | Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform | 0.93 | P0DP23 | CALM1 | Calmodulin-1 | P0DP23 | CALM1 | Calmodulin-1 | 1 | P17252 | PRKCA | Protein kinase C alpha type | P0DP23 | CALM1 | Calmodulin-1 | -0.776 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P0DP23 | CALM1 | Calmodulin-1 | -0.772 | P0DP25 | CALM3 | Calmodulin-3 | P0DP23 | CALM1 | Calmodulin-1 | 1 | P0DP24 | CALM2 | Calmodulin-2 | P0DP23 | CALM1 | Calmodulin-1 | 1 | P0DP24 | CALM2 | Calmodulin-2 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | 0.759 | P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | Q05397 | PTK2 | Focal adhesion kinase 1 | 0.932 | P0DP23 | CALM1 | Calmodulin-1 | P17252 | PRKCA | Protein kinase C alpha type | -0.776 | P17252 | PRKCA | Protein kinase C alpha type | P17252 | PRKCA | Protein kinase C alpha type | 1 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P17252 | PRKCA | Protein kinase C alpha type | 0.844 | P0DP25 | CALM3 | Calmodulin-3 | P17252 | PRKCA | Protein kinase C alpha type | -0.776 | P0DP24 | CALM2 | Calmodulin-2 | P17252 | PRKCA | Protein kinase C alpha type | -0.776 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | O00463 | TRAF5 | TNF receptor-associated factor 5 | 0.773 | P0DP24 | CALM2 | Calmodulin-2 | P61769 | B2M | Beta-2-microglobulin | 0.787 | P17252 | PRKCA | Protein kinase C alpha type | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | 0.786 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | 0.858 | P0DP23 | CALM1 | Calmodulin-1 | P01568 | IFNA21 | Interferon alpha-21 | -0.852 | P17252 | PRKCA | Protein kinase C alpha type | P01568 | IFNA21 | Interferon alpha-21 | 0.733 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P01568 | IFNA21 | Interferon alpha-21 | 0.721 | P0DP25 | CALM3 | Calmodulin-3 | P01568 | IFNA21 | Interferon alpha-21 | -0.852 | P0DP24 | CALM2 | Calmodulin-2 | P01568 | IFNA21 | Interferon alpha-21 | -0.852 | P0DP23 | CALM1 | Calmodulin-1 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | -0.703 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | 0.807 | P0DP25 | CALM3 | Calmodulin-3 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | -0.703 | P0DP24 | CALM2 | Calmodulin-2 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | -0.703 | P17252 | PRKCA | Protein kinase C alpha type | O60603 | TLR2 | Toll-like receptor 2 | -0.716 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | O60603 | TLR2 | Toll-like receptor 2 | -0.884 | P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | Q13315 | ATM | Serine-protein kinase ATM | -0.748 | P17252 | PRKCA | Protein kinase C alpha type | Q13315 | ATM | Serine-protein kinase ATM | 0.739 | P0DP23 | CALM1 | Calmodulin-1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.744 | P0DP25 | CALM3 | Calmodulin-3 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.744 | P0DP24 | CALM2 | Calmodulin-2 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.744 | P0DP23 | CALM1 | Calmodulin-1 | P23528 | CFL1 | Cofilin-1 | -0.832 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P23528 | CFL1 | Cofilin-1 | 0.741 | P0DP25 | CALM3 | Calmodulin-3 | P23528 | CFL1 | Cofilin-1 | -0.832 | P0DP24 | CALM2 | Calmodulin-2 | P23528 | CFL1 | Cofilin-1 | -0.832 | P0DP23 | CALM1 | Calmodulin-1 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.772 | P17252 | PRKCA | Protein kinase C alpha type | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.844 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 1 | P0DP25 | CALM3 | Calmodulin-3 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.772 | P0DP24 | CALM2 | Calmodulin-2 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.772 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q93034 | CUL5 | Cullin-5 | 0.704 | P0DP23 | CALM1 | Calmodulin-1 | Q9Y6Q5 | AP1M2 | AP-1 complex subunit mu-2 | 0.742 | P17252 | PRKCA | Protein kinase C alpha type | Q9Y6Q5 | AP1M2 | AP-1 complex subunit mu-2 | -0.829 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q9Y6Q5 | AP1M2 | AP-1 complex subunit mu-2 | -0.901 | P0DP25 | CALM3 | Calmodulin-3 | Q9Y6Q5 | AP1M2 | AP-1 complex subunit mu-2 | 0.742 | P0DP24 | CALM2 | Calmodulin-2 | Q9Y6Q5 | AP1M2 | AP-1 complex subunit mu-2 | 0.742 |
| Pimozide | hsa05200 | Pathways in cancer | 5.45E-11 | 41 | Q13751, P42338, P23458, P08238, P42224, P19174, Q15311, Q9UJU2, P17252, P43246, P84022, Q13485, Q13547, P14923, P30281, P10415, Q13489, P49767, Q12778, P31751, P43657, P25116, Q08828, P51828, P62873, P63218, P50151, Q14344, Q7LDG7, P61073, P78417, O75293, Q15788, P0DP23, Q13557, O43521, P01568, P14784, P16871, P00734, P01042 | LAMB3, PIK3CB, JAK1, HSP90AB1, STAT1, PLCG1, RALBP1, LEF1, PRKCA, MSH2, SMAD3, SMAD4, HDAC1, JUP, CCND3, BCL2, BIRC3, VEGFC, FOXO1, AKT2, P2RY5, F2R, ADCY1, ADCY7, GNB1, GNG5, GNG10, GNA13, RASGRP2, CXCR4, GSTO1, GADD45B, NCOA1, CALM1, CAMK2D, BCL2L11, IFNA21, IL2RB, IL7R, F2, KNG1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13751 | LAMB3 | Laminin subunit beta-3 | 0.844 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.777 | P0DP23 | CALM1 | Calmodulin-1 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.822 | P0DP24 | CALM2 | Calmodulin-2 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.738 | P0DP23 | CALM1 | Calmodulin-1 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.775 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.823 | P0DP25 | CALM3 | Calmodulin-3 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.775 | P0DP24 | CALM2 | Calmodulin-2 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.775 | P0DP23 | CALM1 | Calmodulin-1 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.775 | P17252 | PRKCA | Protein kinase C alpha type | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | -0.706 | P0DP25 | CALM3 | Calmodulin-3 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.775 | P0DP24 | CALM2 | Calmodulin-2 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.775 | P0DP23 | CALM1 | Calmodulin-1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.744 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.766 | P0DP25 | CALM3 | Calmodulin-3 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.744 | P0DP24 | CALM2 | Calmodulin-2 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.744 | P0DP23 | CALM1 | Calmodulin-1 | Q15311 | RALBP1 | RalA-binding protein 1 | 0.858 | P17252 | PRKCA | Protein kinase C alpha type | Q9UJU2 | LEF1 | Lymphoid enhancer-binding factor 1 | 0.881 | P0DP23 | CALM1 | Calmodulin-1 | P17252 | PRKCA | Protein kinase C alpha type | -0.776 | P17252 | PRKCA | Protein kinase C alpha type | P17252 | PRKCA | Protein kinase C alpha type | 1 | P0DP25 | CALM3 | Calmodulin-3 | P17252 | PRKCA | Protein kinase C alpha type | -0.776 | P0DP24 | CALM2 | Calmodulin-2 | P17252 | PRKCA | Protein kinase C alpha type | -0.776 | P0DP23 | CALM1 | Calmodulin-1 | P43246 | MSH2 | DNA mismatch repair protein Msh2 | 0.944 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P43246 | MSH2 | DNA mismatch repair protein Msh2 | -0.811 | P0DP25 | CALM3 | Calmodulin-3 | P43246 | MSH2 | DNA mismatch repair protein Msh2 | 0.944 | P0DP24 | CALM2 | Calmodulin-2 | P43246 | MSH2 | DNA mismatch repair protein Msh2 | 0.944 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | 0.725 | P0DP23 | CALM1 | Calmodulin-1 | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | 0.777 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.746 | P0DP25 | CALM3 | Calmodulin-3 | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | 0.777 | P0DP24 | CALM2 | Calmodulin-2 | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | 0.777 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13547 | HDAC1 | Histone deacetylase 1 | -0.754 | P0DP23 | CALM1 | Calmodulin-1 | P14923 | JUP | Junction plakoglobin | -0.852 | P17252 | PRKCA | Protein kinase C alpha type | P14923 | JUP | Junction plakoglobin | 0.761 | P0DP25 | CALM3 | Calmodulin-3 | P14923 | JUP | Junction plakoglobin | -0.852 | P0DP24 | CALM2 | Calmodulin-2 | P14923 | JUP | Junction plakoglobin | -0.852 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P30281 | CCND3 | G1/S-specific cyclin-D3 | 0.743 | P0DP23 | CALM1 | Calmodulin-1 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.772 | P17252 | PRKCA | Protein kinase C alpha type | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.844 | P0DP25 | CALM3 | Calmodulin-3 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.772 | P0DP24 | CALM2 | Calmodulin-2 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.772 | P0DP23 | CALM1 | Calmodulin-1 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.8 | P17252 | PRKCA | Protein kinase C alpha type | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.849 | P0DP25 | CALM3 | Calmodulin-3 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.8 | P0DP24 | CALM2 | Calmodulin-2 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.8 | P0DP23 | CALM1 | Calmodulin-1 | P49767 | VEGFC | Vascular endothelial growth factor C | -0.84 | P17252 | PRKCA | Protein kinase C alpha type | P49767 | VEGFC | Vascular endothelial growth factor C | 0.719 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P49767 | VEGFC | Vascular endothelial growth factor C | 0.743 | P0DP25 | CALM3 | Calmodulin-3 | P49767 | VEGFC | Vascular endothelial growth factor C | -0.84 | P0DP24 | CALM2 | Calmodulin-2 | P49767 | VEGFC | Vascular endothelial growth factor C | -0.84 | P17252 | PRKCA | Protein kinase C alpha type | Q12778 | FOXO1 | Forkhead box protein O1 | 0.863 | P0DP23 | CALM1 | Calmodulin-1 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 0.761 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | -0.735 | P17252 | PRKCA | Protein kinase C alpha type | P25116 | F2R | Proteinase-activated receptor 1 | 0.857 | P0DP23 | CALM1 | Calmodulin-1 | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.725 | P0DP24 | CALM2 | Calmodulin-2 | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.711 | P0DP23 | CALM1 | Calmodulin-1 | P51828 | ADCY7 | Adenylate cyclase type 7 | 0.719 | P0DP23 | CALM1 | Calmodulin-1 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.853 | P17252 | PRKCA | Protein kinase C alpha type | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.852 | P0DP25 | CALM3 | Calmodulin-3 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.853 | P0DP24 | CALM2 | Calmodulin-2 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.853 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.941 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.948 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q14344 | GNA13 | Guanine nucleotide-binding protein subunit alpha-13 | 0.87 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q7LDG7 | RASGRP2 | RAS guanyl-releasing protein 2 | 0.704 | P0DP24 | CALM2 | Calmodulin-2 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | 0.759 | P0DP23 | CALM1 | Calmodulin-1 | P78417 | GSTO1 | Glutathione S-transferase omega-1 | -0.804 | P0DP25 | CALM3 | Calmodulin-3 | P78417 | GSTO1 | Glutathione S-transferase omega-1 | -0.804 | P0DP24 | CALM2 | Calmodulin-2 | P78417 | GSTO1 | Glutathione S-transferase omega-1 | -0.804 | P0DP23 | CALM1 | Calmodulin-1 | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.853 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | 0.731 | P0DP25 | CALM3 | Calmodulin-3 | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.853 | P0DP24 | CALM2 | Calmodulin-2 | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.853 | P0DP24 | CALM2 | Calmodulin-2 | Q15788 | NCOA1 | Nuclear receptor coactivator 1 | 0.731 | P0DP23 | CALM1 | Calmodulin-1 | P0DP23 | CALM1 | Calmodulin-1 | 1 | P17252 | PRKCA | Protein kinase C alpha type | P0DP23 | CALM1 | Calmodulin-1 | -0.776 | P0DP25 | CALM3 | Calmodulin-3 | P0DP23 | CALM1 | Calmodulin-1 | 1 | P0DP24 | CALM2 | Calmodulin-2 | P0DP23 | CALM1 | Calmodulin-1 | 1 | P0DP24 | CALM2 | Calmodulin-2 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | 0.786 | P0DP24 | CALM2 | Calmodulin-2 | O43521 | BCL2L11 | Bcl-2-like protein 11 | 0.75 | P0DP23 | CALM1 | Calmodulin-1 | P01568 | IFNA21 | Interferon alpha-21 | -0.852 | P17252 | PRKCA | Protein kinase C alpha type | P01568 | IFNA21 | Interferon alpha-21 | 0.733 | P0DP25 | CALM3 | Calmodulin-3 | P01568 | IFNA21 | Interferon alpha-21 | -0.852 | P0DP24 | CALM2 | Calmodulin-2 | P01568 | IFNA21 | Interferon alpha-21 | -0.852 | P0DP23 | CALM1 | Calmodulin-1 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.801 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.835 | P0DP25 | CALM3 | Calmodulin-3 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.801 | P0DP24 | CALM2 | Calmodulin-2 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.801 | P0DP23 | CALM1 | Calmodulin-1 | P16871 | IL7R | Interleukin-7 receptor subunit alpha | 0.718 | P0DP23 | CALM1 | Calmodulin-1 | P00734 | F2 | Prothrombin | -0.738 | P0DP23 | CALM1 | Calmodulin-1 | P01042 | KNG1 | Kininogen-1 | -0.71 | P0DP25 | CALM3 | Calmodulin-3 | P01042 | KNG1 | Kininogen-1 | -0.71 | P0DP24 | CALM2 | Calmodulin-2 | P01042 | KNG1 | Kininogen-1 | -0.71 |
| Pimozide | hsa05202 | Transcriptional misregulation in cancer | 1.79E-09 | 24 | Q12778, Q15532, P41732, P17844, P14780, P27930, P14923, Q15744, Q16548, Q13489, Q13077, O15550, P08069, P04637, P35226, P05164, P12838, P08246, Q9C0K0, P41182, Q13547, Q92769, P12980, P24522 | FOXO1, SS18, TSPAN7, DDX5, MMP9, IL1R2, JUP, CEBPE, BCL2A1, BIRC3, TRAF1, UTX, IGF1R, TP53, BMI1, MPO, DEFA4, ELA2, BCL11B, BCL6, HDAC1, HDAC2, LYL1, GADD45A | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | Q12778 | FOXO1 | Forkhead box protein O1 | 0.714 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q12778 | FOXO1 | Forkhead box protein O1 | 0.794 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | Q15532 | SS18 | Protein SSXT | 0.893 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q15532 | SS18 | Protein SSXT | 0.877 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P41732 | TSPAN7 | Tetraspanin-7 | -0.834 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P41732 | TSPAN7 | Tetraspanin-7 | 0.703 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P17844 | DDX5 | Probable ATP-dependent RNA helicase DDX5 | 0.863 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P14780 | MMP9 | Matrix metalloproteinase-9 | -0.72 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P14780 | MMP9 | Matrix metalloproteinase-9 | 0.94 | P14780 | MMP9 | Matrix metalloproteinase-9 | P14780 | MMP9 | Matrix metalloproteinase-9 | 1 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P14780 | MMP9 | Matrix metalloproteinase-9 | 0.942 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P14780 | MMP9 | Matrix metalloproteinase-9 | -0.765 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.926 | P14780 | MMP9 | Matrix metalloproteinase-9 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.851 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.924 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P14923 | JUP | Junction plakoglobin | 0.914 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P14923 | JUP | Junction plakoglobin | 0.861 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q15744 | CEBPE | CCAAT/enhancer-binding protein epsilon | 0.7 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.958 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.921 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.913 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.746 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.71 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.848 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.796 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.758 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.712 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q13077 | TRAF1 | TNF receptor-associated factor 1 | 0.816 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | O15550 | UTX | Lysine-specific demethylase 6A | -0.808 | P08069 | IGF1R | Insulin-like growth factor 1 receptor | P08069 | IGF1R | Insulin-like growth factor 1 receptor | 1 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P04637 | TP53 | Cellular tumor antigen p53 | 0.753 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.778 | P14780 | MMP9 | Matrix metalloproteinase-9 | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.89 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.778 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P35226 | BMI1 | Polycomb complex protein BMI-1 | 0.78 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.778 | P14780 | MMP9 | Matrix metalloproteinase-9 | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.89 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.778 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P35226 | BMI1 | Polycomb complex protein BMI-1 | 0.78 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P05164 | MPO | Myeloperoxidase | -0.754 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P05164 | MPO | Myeloperoxidase | 0.719 | P14780 | MMP9 | Matrix metalloproteinase-9 | P05164 | MPO | Myeloperoxidase | 0.812 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P05164 | MPO | Myeloperoxidase | 0.711 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P05164 | MPO | Myeloperoxidase | -0.81 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P12838 | DEFA4 | Neutrophil defensin 4 | 0.784 | P14780 | MMP9 | Matrix metalloproteinase-9 | P12838 | DEFA4 | Neutrophil defensin 4 | 0.858 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P12838 | DEFA4 | Neutrophil defensin 4 | 0.767 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P08246 | ELA2 | Neutrophil elastase | -0.833 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P08246 | ELA2 | Neutrophil elastase | 0.702 | P14780 | MMP9 | Matrix metalloproteinase-9 | P08246 | ELA2 | Neutrophil elastase | 0.859 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P08246 | ELA2 | Neutrophil elastase | 0.703 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P08246 | ELA2 | Neutrophil elastase | -0.942 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | 0.741 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | -0.783 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | -0.752 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | -0.765 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | 0.766 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P41182 | BCL6 | B-cell lymphoma 6 protein | 0.919 | P14780 | MMP9 | Matrix metalloproteinase-9 | P41182 | BCL6 | B-cell lymphoma 6 protein | 0.812 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P41182 | BCL6 | B-cell lymphoma 6 protein | 0.9 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q13547 | HDAC1 | Histone deacetylase 1 | -0.7 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q13547 | HDAC1 | Histone deacetylase 1 | -0.742 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q92769 | HDAC2 | Histone deacetylase 2 | -0.7 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q92769 | HDAC2 | Histone deacetylase 2 | -0.746 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P12980 | LYL1 | Protein lyl-1 | 0.784 | P14780 | MMP9 | Matrix metalloproteinase-9 | P12980 | LYL1 | Protein lyl-1 | 0.716 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P12980 | LYL1 | Protein lyl-1 | 0.782 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.768 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.819 | P14780 | MMP9 | Matrix metalloproteinase-9 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.765 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.801 |
| Pimozide | hsa05203 | Viral carcinogenesis | 2.93E-03 | 3 | Q15283, P62807, O60814 | RASA2, HIST1H2BC, H2BC12 | More | | Pimozide | hsa05204 | Chemical carcinogenesis | 2.59E-04 | 4 | P00325, P78417, P11712, P33260 | ADH1B, GSTO1, CYP2C9, CYP2C18 | More | | Pimozide | hsa05205 | Proteoglycans in cancer | 2.34E-05 | 17 | Q13009, Q12955, Q14643, O75369, P63261, P04049, P04637, P14780, P17252, O60603, P01375, P08069, P23588, P04628, Q13635, P22694, P08962 | TIAM1, ANK3, ITPR1, FLNB, ACTG1, RAF1, TP53, MMP9, PRKCA, TLR2, TNF, IGF1R, EIF4B, WNT1, PTCH1, PRKACB, CD63 | More | | Pimozide | hsa05206 | MicroRNAs in cancer | 7.37E-05 | 7 | P15311, P21860, P61978, P46531, P63279, P22105, P04049 | VIL2, ERBB3, HNRPK, NOTCH1, UBE2I, TNXB, RAF1 | More | | Pimozide | hsa05210 | Colorectal cancer | 1.66E-02 | 1 | P04049 | RAF1 | More | | Pimozide | hsa05211 | Renal cell carcinoma | 1.43E-03 | 3 | Q06124, Q99814, P04049 | PTPN11, EPAS1, RAF1 | More | | Pimozide | hsa05212 | Pancreatic cancer | 1.50E-04 | 9 | P42338, P31751, P04049, Q15311, P23458, P42224, P84022, Q13485, O75293 | PIK3CB, AKT2, RAF1, RALBP1, JAK1, STAT1, SMAD3, SMAD4, GADD45B | More | | Pimozide | hsa05213 | Endometrial cancer | 9.95E-03 | 1 | P04049 | RAF1 | More | | Pimozide | hsa05214 | Glioma | 7.94E-07 | 8 | P08069, P0DP23, Q13557, P17252, P04049, P31751, P19174, O75293 | IGF1R, CALM1, CAMK2D, PRKCA, RAF1, AKT2, PLCG1, GADD45B | More | | Pimozide | hsa05215 | Prostate cancer | 1.65E-04 | 2 | P08069, P04049 | IGF1R, RAF1 | More | | Pimozide | hsa05216 | Thyroid cancer | 3.35E-03 | 5 | P01106, Q9UJU2, P04637, P24522, O75293 | MYC, LEF1, TP53, GADD45A, GADD45B | More | | Pimozide | hsa05217 | Basal cell carcinoma | 1.39E-03 | 5 | Q13635, P49841, Q9UJU2, P04637, P24522 | PTCH1, GSK3B, LEF1, TP53, GADD45A | More | | Pimozide | hsa05218 | Melanoma | 3.85E-05 | 2 | P08069, P04049 | IGF1R, RAF1 | More | | Pimozide | hsa05219 | Bladder cancer | 5.65E-03 | 3 | P14780, P04637, P04049 | MMP9, TP53, RAF1 | More | | Pimozide | hsa05220 | Chronic myeloid leukemia | 3.00E-03 | 6 | Q13547, Q13485, P84022, P42338, P04049, O75293 | HDAC1, SMAD4, SMAD3, PIK3CB, RAF1, GADD45B | More | | Pimozide | hsa05221 | Acute myeloid leukemia | 8.29E-03 | 1 | P04049 | RAF1 | More | | Pimozide | hsa05222 | Small cell lung cancer | 4.78E-02 | 1 | Q16787 | LAMA3 | More | | Pimozide | hsa05223 | Non-small cell lung cancer | 1.52E-04 | 7 | P17252, O43524, P19174, P10826, P04049, Q9HC35, O75293 | PRKCA, FOXO3, PLCG1, RARB, RAF1, EML4, GADD45B | More | | Pimozide | hsa05224 | Breast cancer | 2.75E-03 | 6 | P04049, P08069, P49841, Q92837, P04637, P24522 | RAF1, IGF1R, GSK3B, FRAT1, TP53, GADD45A | More | | Pimozide | hsa05225 | Hepatocellular carcinoma | 1.50E-04 | 4 | P04049, P08069, P60709, P63261 | RAF1, IGF1R, ACTB, ACTG1 | More | | Pimozide | hsa05226 | Gastric cancer | 8.29E-03 | 1 | P04049 | RAF1 | More | | Pimozide | hsa05230 | Central carbon metabolism in cancer | 9.95E-03 | 1 | P04049 | RAF1 | More | | Pimozide | hsa05231 | Choline metabolism in cancer | 8.00E-04 | 7 | P04049, Q9Y259, P19174, P23743, P49619, O14494, P17252 | RAF1, CHKB, PLCG1, DGKA, DGKG, PLPP1, PRKCA | More | | Pimozide | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 3.39E-06 | 14 | P42338, O95267, P19174, P07766, P20963, P09693, P06239, P04049, P23458, O60603, Q04759, Q16539, Q9HC35, P01730 | PIK3CB, RASGRP1, PLCG1, CD3E, CD247, CD3G, LCK, RAF1, JAK1, TLR2, PRKCQ, MAPK14, EML4, CD4 | More | | Pimozide | hsa05310 | Asthma | 2.81E-02 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | | Pimozide | hsa05320 | Autoimmune thyroid disease | 2.92E-05 | 4 | P13765, P29965, P01568, P10747 | HLA-DOB, CD40LG, IFNA21, CD28 | More | | Pimozide | hsa05321 | Inflammatory bowel disease | 1.06E-07 | 7 | O60603, P01375, P13765, Q14765, Q9UL17, P23771, P01584 | TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3, IL1B | More | | Pimozide | hsa05322 | Systemic lupus erythematosus | 4.90E-07 | 10 | P08246, P09871, P10747, P13765, P29965, Q6FI13, Q93077, P62807, O60814, P68431 | ELA2, C1S, CD28, HLA-DOB, CD40LG, H2AC18; H2AC19, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Pimozide | hsa05323 | Rheumatoid arthritis | 1.22E-03 | 5 | P13765, Q13488, P10747, P09341, O60603 | HLA-DOB, TCIRG1, CD28, CXCL1, TLR2 | More | | Pimozide | hsa05330 | Allograft rejection | 1.04E-03 | 5 | P13765, P29965, P48023, P10747, P01375 | HLA-DOB, CD40LG, FASLG, CD28, TNF | More | | Pimozide | hsa05332 | Graft-versus-host disease | 1.15E-05 | 5 | P13765, P48023, P01375, P26715, Q13241 | HLA-DOB, FASLG, TNF, KLRC1, KLRD1 | More | | Pimozide | hsa05340 | Primary immunodeficiency | 8.85E-05 | 4 | P01730, P11912, P07766, P06239 | CD4, CD79A, CD3E, LCK | More | | Pimozide | hsa05410 | Hypertrophic cardiomyopathy | 1.18E-03 | 4 | P26012, P09493, P60709, P63261 | ITGB8, TPM1, ACTB, ACTG1 | More | | Pimozide | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 1.58E-04 | 5 | P54284, P15924, P26012, P60709, P63261 | CACNB3, DSP, ITGB8, ACTB, ACTG1 | More | | Pimozide | hsa05414 | Dilated cardiomyopathy | 1.73E-02 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Pimozide | hsa05415 | Diabetic cardiomyopathy | 2.36E-04 | 8 | P17252, P14598, Q15080, Q16718, O14521, Q16539, P49841, P04406 | PRKCA, NCF1, NCF4, NDUFA5, SDHD, MAPK14, GSK3B, GAPDH | More | | Pimozide | hsa05416 | Viral myocarditis | 2.25E-03 | 5 | P13765, P29965, P10747, P60709, P63261 | HLA-DOB, CD40LG, CD28, ACTB, ACTG1 | More | | Pimozide | hsa05418 | Fluid shear stress and atherosclerosis | 8.97E-06 | 15 | Q16539, P14598, P78417, P10599, P14780, P01375, P60709, P63261, P04637, P10415, P14778, P27930, P0DP23, P08238, Q92974 | MAPK14, NCF1, GSTO1, TXN, MMP9, TNF, ACTB, ACTG1, TP53, BCL2, IL1R1, IL1R2, CALM1, HSP90AB1, ARHGEF2 | More | | |